≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other specified and unspecified retinal disorders

DOID EFO Endpoint Browser PheWeb

H7_RETINANAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H35.8, H35.9
  • Hospital discharge: ICD-9 — 3628X
  • Hospital discharge: ICD-8 — 37798
  • Cause of death: ICD-10 — H35.8, H35.9
  • Cause of death: ICD-9 — 3628X
  • Cause of death: ICD-8 — 37798

2 out of 7 registries used, show all original rules.

1437

4. Check minimum number of events

None

1437

5. Include endpoints

None

1437

6. Filter based on genotype QC (FinnGen only)

1382

Control definitions (FinnGen only)

Control exclude
H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8708 4643 4018
Only index persons 8147 4406 3741
Unadjusted period prevalence (%)
Whole population 0.12 0.13 0.11
Only index persons 0.15 0.16 0.14
Median age at first event (years)
Whole population 63.59 66.40 60.51
Only index persons 63.65 66.36 60.46

-FinnGen-

Key figures

All Female Male
Number of individuals 1382 750 632
Unadjusted period prevalence (%) 0.28 0.27 0.29
Median age at first event (years) 64.38 64.41 64.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1437
Matched controls
14370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XCD20
NOMESCO Finland
Photoangiography of eye
174.9
317.0
156
10
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
467.3
310.8
300
8
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
105.8
310.4
160
17
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
35.7
309.3
198
64
H35.9
ICD-10 Finland
Retinal disorder, unspecified
2435.7
307.7
661
5
CKC12
NOMESCO Finland
Photocoagulation of retina
148.7
307.7
182
14
H35.8
ICD-10 Finland
Other specified retinal disorders
+∞
307.7
766
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
12.2
307.7
465
543
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
20.5
307.7
566
441
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
295.2
307.7
245
10
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
296.6
307.7
340
15
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
20.2
307.7
399
268
XCK10
NOMESCO Finland
Photography of fundus of eye
8.4
235.0
359
550
WX140
NOMESCO Finland
Parabulbar anesthesy
16.8
213.7
186
126
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.7
207.9
536
1367
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
54.8
179.0
102
20
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.3
166.6
421
1035
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
66.8
138.3
76
12
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
1295.2
123.9
119
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
12.7
119.9
120
102
H34.8
ICD-10 Finland
Other retinal vascular occlusions
298.5
109.6
110
*
H35.7
ICD-10 Finland
Separation of retinal layers
+∞
108.7
103
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
17.7
99.4
82
49
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
37.1
91.3
57
16
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
465.6
89.2
88
*
XCK00
NOMESCO Finland
Perimetry
5.5
85.2
180
367
XCH00
NOMESCO Finland
Eye pressure measurement
6.0
76.5
142
256
H33.0
ICD-10 Finland
Retinal detachment with retinal break
766.8
74.9
73
*
H35.36
ICD-10 Finland
Macular cyst
755.7
73.9
72
*
H26.4
ICD-10 Finland
After-cataract
3.8
73.3
255
766
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
160.3
72.7
76
5
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.7
69.6
635
3298
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.1
68.4
213
590
H25.1
ICD-10 Finland
Senile nuclear cataract
2.7
66.5
560
2783
CK9G4
NOMESCO Finland
Iridocyanine green angiography (ICGA) of choroid and retina
+∞
65.1
62
*
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
336.8
65.0
65
*
S01ED51
ATC
timolol, combinations; ophthalmic
4.0
61.9
193
534
ZXA10
NOMESCO Finland
Bilateral
2.8
59.9
372
1570
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
131.7
59.3
63
5
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
+∞
58.7
56
*
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
194.1
54.4
56
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
547.8
53.9
53
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.4
53.4
597
3309
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
87.9
53.3
59
7
CKC10
NOMESCO Finland
Local photocoagulation of retina
186.9
52.3
54
*
H33.3
ICD-10 Finland
Retinal breaks without detachment
183.3
51.3
53
*
XCW10
NOMESCO Finland
Assessment of vision
9.9
49.8
58
61
H35.6
ICD-10 Finland
Retinal haemorrhage
+∞
49.2
47
*
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
472.5
46.6
46
*
H35.37
ICD-10 Finland
Macular holes
461.8
45.5
45
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
3.2
45.4
200
689
37798
ICD-8 Finland
Other diseases of retina and optic nerve, Morbi retinae alii sive NUD
+∞
45.0
43
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
5.0
44.7
101
216
H20.1
ICD-10 Finland
Chronic iridocyclitis
13.6
43.5
41
31
S01BC03
ATC
diclofenac; ophthalmic
6.6
41.3
68
108
Z3229
NOMESCO Finland
Other healthcare associate professional
3.2
40.3
180
623
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
39.7
705
4551
H53.1
ICD-10 Finland
Subjective visual disturbances
3.4
39.6
158
511
H53.9
ICD-10 Finland
Visual disturbance, unspecified
4.4
36.1
93
221
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
82.3
36.0
40
5
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
11.9
35.3
36
31
H3601, E113,
ICD-10 Finland
+∞
34.5
33
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.6
34.2
84
192
S01EC01
ATC
acetazolamide; systemic
6.4
33.6
56
90
ZXA00
NOMESCO Finland
Right side
2.1
33.5
447
2561
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
65.0
33.2
38
6
H3600, E113,
ICD-10 Finland
+∞
32.4
31
*
H36.01
ICD-10 Finland
Diabetic maculopathy
73.6
32.0
36
5
S01BC05
ATC
ketorolac; ophthalmic
4.1
31.5
89
227
S01ED01
ATC
timolol; ophthalmic
4.3
30.5
80
193
ZXA05
NOMESCO Finland
Left side
2.0
30.2
411
2358
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.1
27.8
34
38
H26.2
ICD-10 Finland
Complicated cataract
9.4
27.5
33
36
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.3
27.0
232
1106
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
142.7
26.7
28
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
7.3
25.1
37
52
H40.0
ICD-10 Finland
Glaucoma suspect
2.7
24.8
147
590
CS494
NOMESCO Finland
Other visual field testing
4.3
24.0
63
152
Z3231
NOMESCO Finland
Registered nurse
1.9
23.9
426
2644
H35.4
ICD-10 Finland
Peripheral retinal degeneration
68.6
23.9
27
*
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
6.9
23.4
36
53
H36.00
ICD-10 Finland
Diabetic background retinopathy
84.8
22.7
25
*
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
+∞
21.9
21
*
S01EC04
ATC
brinzolamide; ophthalmic
3.3
21.9
87
279
114
Kela drug reimbursment
Glaucoma
2.4
21.7
161
717
H34.2
ICD-10 Finland
Other retinal artery occlusions
223.3
21.7
22
*
127
Kela drug reimbursment
Transplant complication
6.0
20.9
37
63
S01EE01
ATC
latanoprost; ophthalmic
2.7
20.8
121
480
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
3.0
20.7
94
326
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
27.5
20.1
27
10
CKC20
NOMESCO Finland
Cryopexy of undetached retina
202.7
19.6
20
*
S01EA05
ATC
brimonidine; ophthalmic
3.9
19.4
58
154
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.0
19.1
54
138
A10AB01
ATC
insulin (human); parenteral
4.7
19.0
44
96
CKD15
NOMESCO Finland
Injection of vitreous substitute
+∞
18.8
18
*
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
192.4
18.6
19
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.3
18.2
47
112
L04AA06
ATC
mycophenolic acid; systemic
4.7
18.0
42
92
Z94.0
ICD-10 Finland
Kidney transplant status
7.3
17.8
26
36
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
13.9
17.8
30
22
H30.2
ICD-10 Finland
Posterior cyclitis
+∞
17.7
17
*
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
4.1
17.2
47
117
Z2221
NOMESCO Finland
Medical doctor
1.7
17.2
393
2584
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
+∞
16.7
16
*
H33.5
ICD-10 Finland
Other retinal detachments
23.3
16.4
23
10
S01EE05
ATC
tafluprost; ophthalmic
3.0
16.1
74
259
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.7
15.8
51
143
A10AA02, ,
ATC
4.3
15.8
40
94
ZXE00
NOMESCO Finland
One hour or less
1.6
15.8
544
3956
CKD20
NOMESCO Finland
Removal of vitreous body substitute
+∞
15.6
15
*
H3601, E103,
ICD-10 Finland
+∞
15.6
15
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
161.7
15.5
16
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
15.3
504
3617
A10AE04
ATC
insulin glargine; parenteral
2.2
15.3
139
673
3628X
ICD-9 Finland
Other retinal disorders[MORBUS RETINAE ALIA DEFINITA]
+∞
14.6
14
*
A10AC01
ATC
insulin (human); parenteral
2.4
14.6
102
442
WX002
NOMESCO Finland
Sedation and analgesia
1.8
14.5
280
1745
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
14.5
438
3071
CK2K4
NOMESCO Finland
Red-free imaging of ocular fundus
151.5
14.5
15
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
151.5
14.5
15
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
36.4
14.5
18
5
A10AA01, ,
ATC
5.1
14.3
30
60
F05
ICPC
Visual disturbance other
3.1
14.3
60
199
H04AA01
ATC
glucagon; nasal, parenteral
5.7
14.2
26
46
A12AA04
ATC
calcium carbonate; oral
4.5
14.1
34
77
ZX198
NOMESCO Finland
Other local administration
11.0
14.0
26
24
L04AX01
ATC
azathioprine; systemic
2.8
13.9
69
252
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
6.3
13.8
23
37
A10AE05
ATC
insulin detemir; parenteral
2.7
13.7
76
294
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.8
13.6
41
110
H3603, E103,
ICD-10 Finland
+∞
13.6
13
*
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
13.6
13
*
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
34.4
13.5
17
5
H25.0
ICD-10 Finland
Senile incipient cataract
2.3
13.4
104
472
T89
ICPC
Diabetes insulin dependent
3.2
13.2
52
166
A10AB05
ATC
insulin aspart; parenteral
2.3
13.1
103
470
H26.02
ICD-10 Finland
Presenil cataract
3.6
13.0
43
123
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
10.2
13.0
25
25
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
28.6
13.0
17
6
H02AB06
ATC
prednisolone; systemic
1.5
12.9
669
5258
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
22.8
12.9
18
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
12.7
525
3930
S01EC54
ATC
brinzolamide, combinations; ophthalmic
4.8
12.6
28
59
H3600, E103,
ICD-10 Finland
+∞
12.5
12
*
H33.2
ICD-10 Finland
Serous retinal detachment
+∞
12.5
12
*
H3603, E113,
ICD-10 Finland
+∞
12.5
12
*
H34.1
ICD-10 Finland
Central retinal artery occlusion
+∞
12.5
12
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.4
12.5
25
27
A02BC02
ATC
pantoprazole; systemic
1.5
12.3
961
8186
S01EA03
ATC
apraclonidine; ophthalmic
9.1
12.3
25
28
A11CC03
ATC
alfacalcidol; systemic
3.4
12.2
44
133
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
11.2
12.0
22
20
Z71.8
ICD-10 Finland
Other specified counselling
1.5
12.0
460
3377
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.2
11.9
108
523
N18.8
ICD-10 Finland
Other chronic renal failure
3.4
11.8
43
131
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
19.1
11.6
17
9
H53.4
ICD-10 Finland
Visual field defects
3.5
11.6
39
113
S01EE03
ATC
bimatoprost; ophthalmic
3.2
11.6
45
143
A98
ICPC
Health maint/preventive medicine
2.3
11.6
1363
12769
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.4
11.6
41
123
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
13.7
11.5
19
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.5
693
5572
ZX120
NOMESCO Finland
Intravenous
1.9
11.2
140
760
L17
ICPC
Foot/toe symptom/complaint
1.5
11.1
432
3173
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
11.1
166
957
N02BE01
ATC
paracetamol; systemic, rectal
1.8
11.0
1263
11565
H44.2
ICD-10 Finland
Degenerative myopia
43.7
10.9
13
*
L04AX03
ATC
methotrexate; systemic
1.9
10.9
141
775
H25.8
ICD-10 Finland
Other senile cataract
1.8
10.9
162
932
ZXD20
NOMESCO Finland
Day surgery
1.8
10.8
175
1033
S01EC03
ATC
dorzolamide; ophthalmic
4.1
10.7
29
72
R42
ICD-10 Finland
Dizziness and giddiness
1.6
10.7
334
2336
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
60.5
10.6
12
*
L04AD02
ATC
tacrolimus; systemic
5.3
10.6
21
40
S01EE04
ATC
travoprost; ophthalmic
3.3
10.4
38
116
1LA05, ,
NOMESCO Finland
+∞
10.4
10
*
AA1AD
NOMESCO Finland
CT of head and brain
1.5
10.4
428
3172
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
9.6
10.3
20
21
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
10.2
275
1858
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
3.7
10.2
31
84
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.3
10.1
80
366
A10AB04
ATC
insulin lispro; parenteral
3.4
10.0
36
109
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
4.7
10.0
23
50
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
40.4
10.0
12
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
5.2
9.8
20
39
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
9.8
74
332
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
9.8
158
931
H52.1
ICD-10 Finland
Myopia
2.8
9.7
49
181
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.7
9.7
30
82
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
9.7
249
1662
CKA10
NOMESCO Finland
Biopsy of vitreous body
55.4
9.7
11
*
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
5.3
9.6
19
36
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
9.5
123
676
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.4
470
3606
C08CA01
ATC
amlodipine; oral
1.4
9.4
558
4419
CK2Z4
NOMESCO Finland
Ocular fundus light imaging (OCT), angiography
+∞
9.4
9
*
CKC30
NOMESCO Finland
Cryopexy of detached retina
+∞
9.4
9
*
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
+∞
9.4
9
*
H31.8
ICD-10 Finland
Other specified disorders of choroid
+∞
9.4
9
*
TCK00
NOMESCO Finland
Photosensitisation of choroid and retina
+∞
9.4
9
*
H33.4
ICD-10 Finland
Traction detachment of retina
+∞
9.4
9
*
L28
ICPC
Limited function/disability (L)
1.6
9.3
283
1960
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
9.3
102
531
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
9.2
311
2205
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
18.7
8.9
13
7
B01AC04
ATC
clopidogrel; oral
1.6
8.9
240
1616
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
24.2
8.9
12
5
L04AD01
ATC
ciclosporin; systemic
3.6
8.9
28
78
137
Kela drug reimbursment
Uraemia requiring dialysis
6.9
8.8
21
31
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
8.8
326
2352
Z31.5
ICD-10 Finland
Genetic counselling
2.3
8.7
68
310
H35
ICD-10 Finland
Other retinal disorders
50.3
8.7
10
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
8.7
174
1089
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
8.7
96
501
A10AD01
ATC
insulin (human); parenteral
4.4
8.6
21
48
TK800
NOMESCO Finland
Hemodialysis
3.1
8.6
36
120
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
8.6
161
989
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.7
8.5
45
171
UJF32
NOMESCO Finland
Coloscopy
1.5
8.5
354
2617
N02AX02
ATC
tramadol; systemic, rectal
1.4
8.5
585
4735
B05DA
ATC
Isotonic solutions
7.4
8.5
19
26
A28
ICPC
Limited function/disability NOS
1.5
8.4
272
1906
H34.9
ICD-10 Finland
Retinal vascular occlusion, unspecified
+∞
8.3
8
*
CKD50
NOMESCO Finland
Endodiathermy of retina
+∞
8.3
8
*
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
+∞
8.3
8
*
B05DB
ATC
Hypertonic solutions
8.6
8.3
17
20
H20.8
ICD-10 Finland
Other iridocyclitis
9.5
8.3
16
17
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
8.3
867
7506
H54.7
ICD-10 Finland
Unspecified visual loss
6.5
8.2
20
31
Z49.2
ICD-10 Finland
Other dialysis
7.6
8.2
18
24
H47.1
ICD-10 Finland
Papilloedema, unspecified
9.0
8.0
16
18
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
10.1
8.0
15
15
CHC05
NOMESCO Finland
Iridotomy
3.6
8.0
26
74
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
7.9
942
8296
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
7.9
181
1170
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
7.9
175
1122
H26.8
ICD-10 Finland
Other specified cataract
4.5
7.9
19
43
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.8
7.9
115
657
J01MA14
ATC
moxifloxacin; systemic
1.8
7.8
124
726
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.8
7.8
23
61
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
7.8
62
285
M79.6
ICD-10 Finland
Pain in limb
1.4
7.8
592
4847
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
10.9
7.8
14
13
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
7.8
89
470
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.7
219
1491
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.3
7.7
28
86
XCH05
NOMESCO Finland
Eye pressure longterm registration
4.5
7.7
18
40
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
7.7
476
3769
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
7.6
70
341
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
2.5
7.6
45
181
J01DB01
ATC
cefalexin; oral
1.4
7.6
1111
10098
CA1ME
NOMESCO Finland
Ultrasound oculometry
6.7
7.6
18
27
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
25.1
7.6
10
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
25.1
7.6
10
*
A04
ICPC
Weakness/tiredness general
1.5
7.6
217
1480
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.5
839
7284
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
7.5
331
2467
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
7.5
126
752
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
7.4
56
253
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.0
7.4
20
50
WX142
NOMESCO Finland
Sub-tenon anesthesy
8.4
7.3
15
18
F29
ICPC
Eye symptom/complaint other
1.7
7.3
141
873
1LA04, ,
NOMESCO Finland
+∞
7.3
7
*
H3602, E113,
ICD-10 Finland
+∞
7.3
7
*
CKC70
NOMESCO Finland
Circular buckling of sclera
+∞
7.3
7
*
1LA01, ,
NOMESCO Finland
+∞
7.3
7
*
CKC60
NOMESCO Finland
Local buckling of sclera using implant
+∞
7.3
7
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
7.3
554
4526
C10AA05
ATC
atorvastatin; oral
1.4
7.2
581
4783
R53
ICD-10 Finland
Malaise and fatigue
1.4
7.2
338
2542
U07
ICPC
Urine symptom/complaint other
1.7
7.2
120
713
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
7.2
347
2623
V03AE01
ATC
polystyrene sulfonate; oral
3.7
7.2
22
60
R05
ICD-10 Finland
Cough
1.5
7.2
277
2009
R4110
NOMESCO Finland
Physiotherapy
1.4
7.2
370
2833
D31.2
ICD-10 Finland
Benign neoplasm: Retina
30.2
7.2
9
*
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
30.2
7.2
9
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
12.1
7.1
12
10
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
7.1
130
795
U02
ICPC
Urinary frequency/urgency
1.5
7.0
205
1402
R05
ICPC
Cough
1.4
7.0
324
2433
CKD60
NOMESCO Finland
Anterior vitrectomy
5.9
6.9
18
31
N03AX16
ATC
[U] pregabalin
1.4
6.9
299
2215
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.9
522
4249
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
8.3
6.8
14
17
P01BA02
ATC
hydroxychloroquine; oral
1.8
6.8
106
618
C09CA06
ATC
candesartan; oral
1.4
6.8
319
2398
H40.11
ICD-10 Finland
Low pressure glaucoma
2.6
6.7
37
144
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.3
6.7
24
73
H02
ICPC
Hearing complaint
1.5
6.7
207
1434
SPAT1263
SPAT
Sampling
1.4
6.7
525
4295
H57.1
ICD-10 Finland
Ocular pain
2.2
6.7
54
251
Z3226
NOMESCO Finland
Physiotherapist
1.5
6.6
238
1703
SFA10
NOMESCO Finland
One-surface restoration
1.3
6.5
685
5840
H40.9
ICD-10 Finland
Glaucoma, unspecified
2.7
6.5
33
123
XQ902
NOMESCO Finland
Other photography
3.7
6.5
20
55
R51.80
ICD-10 Finland
Headache
1.5
6.4
194
1339
U08
ICPC
Urinary retention
2.7
6.4
32
119
Z2446
NOMESCO Finland
Social worker
1.8
6.4
86
481
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
6.3
380
2975
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
6.3
342
2633
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
6.3
287
2146
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
+∞
6.3
6
*
M05BA04
ATC
alendronic acid; oral
1.6
6.2
127
798
H43.2
ICD-10 Finland
Crystalline deposits in vitreous body
26.8
6.2
8
*
A01
ICPC
Pain general/multiple sites
1.6
6.2
143
926
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.2
152
1000
E0000UV, ,
ATC
1.3
6.2
521
4296
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.6
6.2
33
127
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
6.2
147
961
Z2445
NOMESCO Finland
Psychologist
2.2
6.1
48
220
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
6.1
210
1485
B01AB05
ATC
enoxaparin; parenteral
1.4
6.1
413
3291
R35
ICD-10 Finland
Polyuria
1.8
6.1
93
539
S01BA01
ATC
dexamethasone; ophthalmic
2.2
6.1
47
214
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.1
212
1506
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
8.6
6.1
12
14
J01FF01
ATC
clindamycin; systemic
1.4
6.1
341
2640
C08CA13
ATC
lercanidipine; oral
1.5
6.0
202
1422
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
10.1
6.0
11
11
H21.0
ICD-10 Finland
Hyphaema
10.1
6.0
11
11
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
6.0
139
901
F99
ICPC
Eye/adnexa disease other
5.2
6.0
17
33
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.3
6.0
22
68
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
6.0
84
475

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ophthalmology
18 [38004463]
1.3e+00
2.6e+00
3.5e+00
3.6e+01
4.0e+00
3.8e+00
2.2e+00
cases:37.98%
controls:14.57%
cases:44.28%
controls:5.57%
cases:19.53%
controls:0.70%
cases:92.56%
controls:0.04%
cases:30.69%
controls:0.82%
cases:73.34%
controls:5.68%
cases:65.05%
controls:16.58%
531
2033
867
11923
619
778
779
13178
273
97
1125
13859
1294
5
104
13951
429
114
969
13800
993
764
361
12677
709
1781
381
8960
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
2.1e+00
3.3e+00
4.0e+00
—
—
4.6e+00
3.1e+00
cases:5.15%
controls:0.67%
cases:6.51%
controls:0.27%
cases:2.36%
controls:0.04%
—
—
—
—
cases:18.46%
controls:0.24%
cases:18.26%
controls:1.04%
72
93
1326
13863
91
37
1307
13919
33
6
1365
13950
—
—
250
32
1104
13409
199
112
891
10629
Examination of eyes and vision
Z01.0 [45566391]
1.4e+00
2.5e+00
3.9e+00
—
3.6e+00
2.9e+00
1.7e+00
cases:7.65%
controls:2.02%
cases:8.08%
controls:0.73%
cases:4.08%
controls:0.09%
—
—
cases:2.22%
controls:0.06%
cases:11.15%
controls:0.71%
cases:13.12%
controls:2.60%
107
282
1291
13674
113
102
1285
13854
57
12
1341
13944
—
31
9
1367
13905
151
96
1203
13345
143
279
947
10462
Other investigative procedure of eye
XCW99 [2001301491]
2.2e+00
3.1e+00
—
1.0e+50
3.7e+00
3.6e+00
2.6e+00
cases:8.51%
controls:1.05%
cases:7.73%
controls:0.39%
—
—
cases:12.45%
controls:0.00%
cases:2.86%
controls:0.07%
cases:13.52%
controls:0.43%
cases:13.39%
controls:1.10%
119
147
1279
13809
108
54
1290
13902
—
174
0
1224
13956
40
10
1358
13904
183
58
1171
13383
146
118
944
10623
Presence of intraocular lens
Z96.1 [45585885]
1.2e+00
2.3e+00
2.8e+00
1.0e+50
4.0e+00
2.9e+00
1.9e+00
cases:4.58%
controls:1.48%
cases:6.08%
controls:0.66%
cases:1.36%
controls:0.09%
cases:6.37%
controls:0.00%
cases:2.93%
controls:0.06%
cases:9.68%
controls:0.60%
cases:13.49%
controls:2.33%
64
206
1334
13750
85
92
1313
13864
19
12
1379
13944
89
0
1309
13956
41
8
1357
13906
131
80
1223
13361
147
250
943
10491
Plain photography of ocular fundus
CK2S4 [2001301455]
1.6e+00
2.7e+00
3.6e+00
1.0e+50
—
3.8e+00
2.7e+00
cases:2.50%
controls:0.51%
cases:3.15%
controls:0.21%
cases:1.36%
controls:0.04%
cases:10.01%
controls:0.00%
—
—
cases:9.38%
controls:0.23%
cases:9.17%
controls:0.68%
35
71
1363
13885
44
30
1354
13926
19
5
1379
13951
140
0
1258
13956
—
127
31
1227
13410
100
73
990
10668
Parabulbar anesthesia
WX140 [2001310772]
2.8e+00
3.5e+00
—
1.0e+50
—
4.3e+00
2.5e+00
cases:2.15%
controls:0.14%
cases:2.50%
controls:0.08%
—
—
cases:0.50%
controls:0.00%
—
—
cases:3.18%
controls:0.04%
cases:3.12%
controls:0.26%
30
19
1368
13937
35
11
1363
13945
—
7
0
1391
13956
—
43
6
1311
13435
34
28
1056
10713
Electrophysiological examination of eye
XCD10 [2001300413]
2.8e+00
3.5e+00
—
1.0e+50
1.0e+50
3.6e+00
3.1e+00
cases:2.15%
controls:0.14%
cases:1.57%
controls:0.05%
—
—
cases:1.50%
controls:0.00%
cases:0.36%
controls:0.00%
cases:2.14%
controls:0.06%
cases:2.20%
controls:0.10%
30
19
1368
13937
22
7
1376
13949
—
21
0
1377
13956
5
0
1393
13914
29
8
1325
13433
24
11
1066
10730
prednisolone
S03BA02 [21605202]
9.0e-01
1.9e+00
2.9e+00
1.0e+50
3.1e+00
2.4e+00
1.3e+00
cases:4.86%
controls:2.03%
cases:4.51%
controls:0.70%
cases:1.50%
controls:0.09%
cases:1.22%
controls:0.00%
cases:2.43%
controls:0.11%
cases:6.20%
controls:0.62%
cases:6.61%
controls:1.88%
68
284
1330
13672
63
98
1335
13858
21
12
1377
13944
17
0
1381
13956
34
15
1364
13899
84
84
1270
13357
72
202
1018
10539
prednisolone
S01BA04 [21603621]
9.0e-01
1.9e+00
2.9e+00
1.0e+50
3.1e+00
2.4e+00
1.3e+00
cases:4.86%
controls:2.03%
cases:4.51%
controls:0.70%
cases:1.50%
controls:0.09%
cases:1.22%
controls:0.00%
cases:2.43%
controls:0.11%
cases:6.20%
controls:0.62%
cases:6.61%
controls:1.88%
68
284
1330
13672
63
98
1335
13858
21
12
1377
13944
17
0
1381
13956
34
15
1364
13899
84
84
1270
13357
72
202
1018
10539
Chronic iridocyclitis
H20.1 [45562191]
2.6e+00
3.3e+00
—
1.0e+50
—
3.3e+00
3.1e+00
cases:1.07%
controls:0.08%
cases:1.14%
controls:0.04%
—
—
cases:0.57%
controls:0.00%
—
—
cases:1.03%
controls:0.04%
cases:1.65%
controls:0.07%
15
11
1383
13945
16
6
1382
13950
—
8
0
1390
13956
—
14
5
1340
13436
18
8
1072
10733
Eye pressure measurement
XCH00 [2001301234]
1.5e+00
2.4e+00
3.5e+00
1.0e+50
—
2.7e+00
2.0e+00
cases:1.86%
controls:0.41%
cases:1.93%
controls:0.18%
cases:1.14%
controls:0.04%
cases:1.79%
controls:0.00%
—
—
cases:3.62%
controls:0.26%
cases:4.68%
controls:0.67%
26
57
1372
13899
27
25
1371
13931
16
5
1382
13951
25
0
1373
13956
—
49
35
1305
13406
51
72
1039
10669
Kuhnt-Junius degeneration
H35.30 [2000502314]
4.0e+00
—
1.0e+50
1.0e+50
—
4.4e+00
3.6e+00
cases:2.58%
controls:0.05%
—
—
cases:0.36%
controls:0.00%
cases:1.57%
controls:0.00%
—
—
cases:4.65%
controls:0.06%
cases:6.42%
controls:0.20%
36
7
1362
13949
—
5
0
1393
13956
22
0
1376
13956
—
63
8
1291
13433
70
21
1020
10720
dorzolamide
S01EC03 [21603695]
1.5e+00
1.9e+00
2.5e+00
—
2.2e+00
1.9e+00
1.8e+00
cases:2.29%
controls:0.52%
cases:2.93%
controls:0.46%
cases:0.79%
controls:0.06%
—
—
cases:1.29%
controls:0.15%
cases:3.10%
controls:0.47%
cases:4.22%
controls:0.72%
32
72
1366
13884
41
64
1357
13892
11
9
1387
13947
—
18
21
1380
13893
42
63
1312
13378
46
77
1044
10664
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.5e+00
1.5e+00
2.2e+00
—
2.8e+00
2.0e+00
1.4e+00
cases:1.00%
controls:0.23%
cases:0.86%
controls:0.20%
cases:0.64%
controls:0.07%
—
—
cases:0.72%
controls:0.04%
cases:1.55%
controls:0.22%
cases:2.02%
controls:0.50%
14
32
1384
13924
12
28
1386
13928
9
10
1389
13946
—
10
6
1388
13908
21
29
1333
13412
22
54
1068
10687
nepafenac
S01BC10 [21603648]
1.2e+00
2.5e+00
—
1.0e+50
4.0e+00
2.4e+00
1.2e+00
cases:3.43%
controls:1.11%
cases:5.08%
controls:0.44%
—
—
cases:3.15%
controls:0.00%
cases:3.58%
controls:0.06%
cases:5.69%
controls:0.54%
cases:6.88%
controls:2.25%
48
155
1350
13801
71
62
1327
13894
—
44
0
1354
13956
50
9
1348
13905
77
72
1277
13369
75
242
1015
10499
Kidney transplant status
Z94.0 [45566477]
2.1e+00
2.1e+00
2.6e+00
1.0e+50
—
2.2e+00
2.2e+00
cases:1.00%
controls:0.13%
cases:1.00%
controls:0.13%
cases:0.57%
controls:0.04%
cases:0.50%
controls:0.00%
—
—
cases:1.03%
controls:0.11%
cases:1.19%
controls:0.14%
14
18
1384
13938
14
18
1384
13938
8
6
1390
13950
7
0
1391
13956
—
14
15
1340
13426
13
15
1077
10726
Outpatient Visit
OP [9202]
5.6e-01
7.6e-01
9.4e-01
5.3e+00
1.2e+00
1.2e+00
9.8e-01
cases:85.19%
controls:76.64%
cases:72.60%
controls:55.44%
cases:25.68%
controls:11.89%
cases:48.21%
controls:0.44%
cases:27.97%
controls:10.49%
cases:80.06%
controls:54.75%
cases:92.48%
controls:82.25%
1191
10696
207
3260
1015
7737
383
6219
359
1659
1039
12297
674
62
724
13894
391
1460
1007
12454
1084
7359
270
6082
1008
8835
82
1906
levofloxacin
S01AE05 [43534860]
7.2e-01
1.8e+00
2.3e+00
1.0e+50
2.7e+00
1.8e+00
8.5e-01
cases:4.86%
controls:2.43%
cases:4.58%
controls:0.79%
cases:0.79%
controls:0.08%
cases:0.64%
controls:0.00%
cases:1.22%
controls:0.09%
cases:5.02%
controls:0.84%
cases:7.61%
controls:3.39%
68
339
1330
13617
64
110
1334
13846
11
11
1387
13945
9
0
1389
13956
17
12
1381
13902
68
113
1286
13328
83
364
1007
10377
tropicamide
S01FA06 [21605065]
1.8e+00
3.2e+00
—
—
—
3.2e+00
2.0e+00
cases:1.14%
controls:0.19%
cases:1.00%
controls:0.04%
—
—
—
—
—
—
cases:0.89%
controls:0.04%
cases:1.74%
controls:0.25%
16
27
1382
13929
14
6
1384
13950
—
—
—
12
5
1342
13436
19
27
1071
10714
Glaucoma suspect
H40.0 [45567051]
7.9e-01
1.2e+00
2.7e+00
1.0e+50
2.8e+00
1.3e+00
1.1e+00
cases:2.15%
controls:0.99%
cases:1.43%
controls:0.42%
cases:0.64%
controls:0.04%
cases:0.86%
controls:0.00%
cases:0.57%
controls:0.04%
cases:1.70%
controls:0.47%
cases:3.58%
controls:1.17%
30
138
1368
13818
20
58
1378
13898
9
6
1389
13950
12
0
1386
13956
8
5
1390
13909
23
63
1331
13378
39
126
1051
10615
Other disorders of vitreous body
H43.8 [45533329]
1.4e+00
2.0e+00
3.2e+00
1.0e+50
—
2.3e+00
1.0e+00
cases:3.08%
controls:0.79%
cases:1.65%
controls:0.24%
cases:0.86%
controls:0.04%
cases:1.50%
controls:0.00%
—
—
cases:2.22%
controls:0.22%
cases:2.94%
controls:1.07%
43
110
1355
13846
23
33
1375
13923
12
5
1386
13951
21
0
1377
13956
—
30
30
1324
13411
32
115
1058
10626
antibiotics in combination with other drugs
S01AA20 [21603571]
6.0e-01
1.7e+00
3.0e+00
—
2.4e+00
1.4e+00
7.4e-01
cases:13.59%
controls:7.97%
cases:11.66%
controls:2.42%
cases:3.58%
controls:0.19%
—
—
cases:3.65%
controls:0.34%
cases:9.90%
controls:2.54%
cases:16.70%
controls:8.76%
190
1112
1208
12844
163
338
1235
13618
50
26
1348
13930
—
51
48
1347
13866
134
341
1220
13100
182
941
908
9800
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
7.2e-01
1.1e+00
2.3e+00
—
2.7e+00
1.5e+00
1.3e+00
cases:2.00%
controls:0.98%
cases:1.36%
controls:0.47%
cases:0.57%
controls:0.06%
—
—
cases:0.86%
controls:0.06%
cases:1.62%
controls:0.36%
cases:3.39%
controls:0.97%
28
137
1370
13819
19
65
1379
13891
8
8
1390
13948
—
12
8
1386
13906
22
48
1332
13393
37
104
1053
10637
Left side
ZXA05 [2001311347]
4.4e-01
1.3e+00
2.7e+00
1.0e+50
2.6e+00
1.6e+00
9.0e-01
cases:6.15%
controls:4.06%
cases:3.08%
controls:0.88%
cases:0.64%
controls:0.04%
cases:1.36%
controls:0.00%
cases:1.00%
controls:0.07%
cases:3.55%
controls:0.71%
cases:5.87%
controls:2.47%
86
566
1312
13390
43
123
1355
13833
9
6
1389
13950
19
0
1379
13956
14
10
1384
13904
48
95
1306
13346
64
265
1026
10476
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.9e+00
2.1e+00
2.1e+00
—
—
1.9e+00
1.6e+00
cases:1.43%
controls:0.21%
cases:1.43%
controls:0.18%
cases:0.50%
controls:0.06%
—
—
—
—
cases:1.33%
controls:0.20%
cases:1.38%
controls:0.28%
20
29
1378
13927
20
25
1378
13931
7
9
1391
13947
—
—
18
27
1336
13414
15
30
1075
10711
brinzolamide, combinations
S01EC54 [45893490]
1.2e+00
1.5e+00
2.2e+00
—
1.3e+00
1.8e+00
1.6e+00
cases:2.86%
controls:0.84%
cases:3.08%
controls:0.72%
cases:1.50%
controls:0.16%
—
—
cases:0.86%
controls:0.24%
cases:3.91%
controls:0.68%
cases:5.23%
controls:1.15%
40
117
1358
13839
43
100
1355
13856
21
23
1377
13933
—
12
33
1386
13881
53
92
1301
13349
57
124
1033
10617
Perimetry
XCK00 [2001301380]
1.5e+00
1.9e+00
—
1.0e+50
2.5e+00
2.2e+00
1.4e+00
cases:3.79%
controls:0.91%
cases:1.93%
controls:0.29%
—
—
cases:1.57%
controls:0.00%
cases:0.43%
controls:0.04%
cases:2.58%
controls:0.28%
cases:2.94%
controls:0.73%
53
127
1345
13829
27
41
1371
13915
—
22
0
1376
13956
6
5
1392
13909
35
38
1319
13403
32
78
1058
10663
Acute and subacute iridocyclitis
H20.0 [45542994]
1.7e+00
2.8e+00
—
1.0e+50
—
2.8e+00
2.2e+00
cases:2.00%
controls:0.36%
cases:2.29%
controls:0.14%
—
—
cases:1.07%
controls:0.00%
—
—
cases:1.85%
controls:0.12%
cases:2.39%
controls:0.27%
28
50
1370
13906
32
20
1366
13936
—
15
0
1383
13956
—
25
16
1329
13425
26
29
1064
10712
Bilateral
ZXA10 [2001311348]
5.3e-01
1.8e+00
1.7e+00
1.0e+50
2.7e+00
2.9e+00
1.5e+00
cases:4.08%
controls:2.43%
cases:3.43%
controls:0.59%
cases:0.36%
controls:0.06%
cases:4.43%
controls:0.00%
cases:0.86%
controls:0.06%
cases:6.57%
controls:0.39%
cases:7.71%
controls:1.82%
57
339
1341
13617
48
82
1350
13874
5
9
1393
13947
62
0
1336
13956
12
8
1386
13906
89
52
1265
13389
84
196
1006
10545
Emergency Room Visit
ER [9203]
3.7e-01
6.2e-01
1.2e+00
5.1e+00
9.5e-01
6.5e-01
5.0e-01
cases:43.42%
controls:34.65%
cases:19.96%
controls:11.83%
cases:5.15%
controls:1.57%
cases:6.65%
controls:0.04%
cases:3.79%
controls:1.49%
cases:18.24%
controls:10.44%
cases:39.17%
controls:28.00%
607
4836
791
9120
279
1651
1119
12305
72
219
1326
13737
93
6
1305
13950
53
208
1345
13706
247
1403
1107
12038
427
3007
663
7734
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.8e+00
1.8e+00
1.4e+00
—
2.3e+00
1.9e+00
1.7e+00
cases:1.36%
controls:0.24%
cases:1.14%
controls:0.20%
cases:0.36%
controls:0.09%
—
—
cases:0.43%
controls:0.04%
cases:1.03%
controls:0.16%
cases:1.19%
controls:0.21%
19
33
1379
13923
16
28
1382
13928
5
12
1393
13944
—
6
6
1392
13908
14
22
1340
13419
13
23
1077
10718
Senile nuclear cataract
H25.1 [45581628]
6.9e-01
2.0e+00
2.6e+00
1.0e+50
1.9e+00
1.4e+00
8.6e-01
cases:8.08%
controls:4.21%
cases:10.01%
controls:1.48%
cases:2.29%
controls:0.17%
cases:4.43%
controls:0.00%
cases:1.50%
controls:0.24%
cases:6.35%
controls:1.70%
cases:11.65%
controls:5.29%
113
588
1285
13368
140
207
1258
13749
32
24
1366
13932
62
0
1336
13956
21
33
1377
13881
86
228
1268
13213
127
568
963
10173
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
H40.10 [2000502332]
1.2e+00
1.6e+00
2.0e+00
1.0e+50
2.1e+00
1.5e+00
1.0e+00
cases:1.29%
controls:0.38%
cases:1.29%
controls:0.27%
cases:0.43%
controls:0.06%
cases:0.86%
controls:0.00%
cases:0.57%
controls:0.07%
cases:1.26%
controls:0.29%
cases:1.74%
controls:0.63%
18
53
1380
13903
18
38
1380
13918
6
8
1392
13948
12
0
1386
13956
8
10
1390
13904
17
39
1337
13402
19
68
1071
10673
brinzolamide
S01EC04 [21603696]
1.2e+00
1.5e+00
2.0e+00
—
1.3e+00
1.8e+00
1.6e+00
cases:2.43%
controls:0.75%
cases:2.65%
controls:0.62%
cases:1.07%
controls:0.14%
—
—
cases:0.79%
controls:0.21%
cases:3.32%
controls:0.58%
cases:4.86%
controls:1.07%
34
104
1364
13852
37
86
1361
13870
15
20
1383
13936
—
11
29
1387
13885
45
78
1309
13363
53
115
1037
10626
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
2.0e+00
2.3e+00
—
—
—
2.5e+00
2.4e+00
cases:0.93%
controls:0.13%
cases:0.93%
controls:0.09%
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.38%
controls:0.12%
13
18
1385
13938
13
13
1385
13943
—
—
—
12
10
1342
13431
15
13
1075
10728
Photography of fundus of eye
XCK10 [2001301381]
1.4e+00
2.7e+00
—
1.0e+50
—
3.0e+00
2.0e+00
cases:5.87%
controls:1.48%
cases:5.15%
controls:0.37%
—
—
cases:6.80%
controls:0.00%
—
—
cases:7.09%
controls:0.36%
cases:6.79%
controls:0.96%
82
206
1316
13750
72
51
1326
13905
—
95
0
1303
13956
—
96
49
1258
13392
74
103
1016
10638
Outpatient Hospital
22 [8756]
3.5e-01
7.3e-01
8.0e-01
4.4e+00
1.2e+00
8.5e-01
6.7e-01
cases:32.90%
controls:25.72%
cases:14.38%
controls:7.46%
cases:2.29%
controls:1.04%
cases:2.79%
controls:0.04%
cases:2.86%
controls:0.86%
cases:12.48%
controls:5.75%
cases:25.41%
controls:14.81%
460
3590
938
10366
201
1041
1197
12915
32
145
1366
13811
39
5
1359
13951
40
120
1358
13794
169
773
1185
12668
277
1591
813
9150
timolol, combinations
S01ED51 [21603705]
1.2e+00
1.5e+00
1.9e+00
—
1.5e+00
1.5e+00
1.3e+00
cases:5.87%
controls:1.85%
cases:6.87%
controls:1.70%
cases:2.50%
controls:0.40%
—
—
cases:2.50%
controls:0.55%
cases:7.31%
controls:1.82%
cases:8.99%
controls:2.54%
82
258
1316
13698
96
237
1302
13719
35
56
1363
13900
—
35
76
1363
13838
99
244
1255
13197
98
273
992
10468
dexamethasone
S03BA01 [21605201]
5.7e-01
1.5e+00
1.7e+00
1.0e+50
2.7e+00
1.5e+00
8.6e-01
cases:4.51%
controls:2.61%
cases:3.86%
controls:0.87%
cases:0.79%
controls:0.14%
cases:1.22%
controls:0.00%
cases:1.86%
controls:0.13%
cases:4.58%
controls:1.08%
cases:8.07%
controls:3.58%
63
364
1335
13592
54
122
1344
13834
11
20
1387
13936
17
0
1381
13956
26
18
1372
13896
62
145
1292
13296
88
385
1002
10356
dexamethasone
S01BA01 [21603618]
5.7e-01
1.5e+00
1.7e+00
1.0e+50
2.7e+00
1.5e+00
8.6e-01
cases:4.51%
controls:2.61%
cases:3.86%
controls:0.87%
cases:0.79%
controls:0.14%
cases:1.22%
controls:0.00%
cases:1.86%
controls:0.13%
cases:4.58%
controls:1.08%
cases:8.07%
controls:3.58%
63
364
1335
13592
54
122
1344
13834
11
20
1387
13936
17
0
1381
13956
26
18
1372
13896
62
145
1292
13296
88
385
1002
10356
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
2.2e+00
2.0e+00
—
—
2.6e+00
2.0e+00
1.4e+00
cases:0.50%
controls:0.06%
cases:0.57%
controls:0.08%
—
—
—
—
cases:0.50%
controls:0.04%
cases:0.66%
controls:0.09%
cases:0.55%
controls:0.13%
7
8
1391
13948
8
11
1390
13945
—
—
7
5
1391
13909
9
12
1345
13429
6
14
1084
10727
brimonidine
S01EA05 [21603677]
1.3e+00
1.7e+00
2.4e+00
—
1.9e+00
1.9e+00
1.5e+00
cases:1.57%
controls:0.43%
cases:1.50%
controls:0.29%
cases:0.57%
controls:0.05%
—
—
cases:0.43%
controls:0.06%
cases:1.70%
controls:0.26%
cases:2.02%
controls:0.46%
22
60
1376
13896
21
40
1377
13916
8
7
1390
13949
—
6
9
1392
13905
23
35
1331
13406
22
49
1068
10692
brimonidine
S01GA07 [947915]
1.3e+00
1.7e+00
2.4e+00
—
1.9e+00
1.9e+00
1.5e+00
cases:1.57%
controls:0.43%
cases:1.50%
controls:0.29%
cases:0.57%
controls:0.05%
—
—
cases:0.43%
controls:0.06%
cases:1.70%
controls:0.26%
cases:2.02%
controls:0.46%
22
60
1376
13896
21
40
1377
13916
8
7
1390
13949
—
6
9
1392
13905
23
35
1331
13406
22
49
1068
10692
Other senile cataract
H25.8 [45605644]
3.7e-01
1.8e+00
2.6e+00
—
2.5e+00
1.7e+00
3.2e-01
cases:2.43%
controls:1.70%
cases:2.86%
controls:0.48%
cases:0.93%
controls:0.07%
—
—
cases:0.72%
controls:0.06%
cases:2.29%
controls:0.45%
cases:2.66%
controls:1.96%
34
237
1364
13719
40
67
1358
13889
13
10
1385
13946
—
10
8
1388
13906
31
60
1323
13381
29
210
1061
10531
prazosin; oral
C02CA01 [21600411]
1.4e+00
1.9e+00
1.8e+00
—
1.9e+00
1.9e+00
1.4e+00
cases:1.14%
controls:0.27%
cases:1.29%
controls:0.19%
cases:0.43%
controls:0.07%
—
—
cases:0.57%
controls:0.09%
cases:1.11%
controls:0.17%
cases:1.47%
controls:0.38%
16
38
1382
13918
18
26
1380
13930
6
10
1392
13946
—
8
12
1390
13902
15
23
1339
13418
16
41
1074
10700
Subjective visual disturbances
H53.1 [45557467]
6.2e-01
2.7e+00
—
1.0e+50
2.6e+00
2.1e+00
1.0e+00
cases:1.22%
controls:0.66%
cases:2.43%
controls:0.17%
—
—
cases:0.79%
controls:0.00%
cases:0.50%
controls:0.04%
cases:1.40%
controls:0.17%
cases:2.57%
controls:0.93%
17
92
1381
13864
34
24
1364
13932
—
11
0
1387
13956
7
5
1391
13909
19
23
1335
13418
28
100
1062
10641
hypromellose
S01KA02 [21605115]
9.7e-01
1.3e+00
1.7e+00
—
1.8e+00
1.4e+00
9.4e-01
cases:5.79%
controls:2.28%
cases:3.58%
controls:0.97%
cases:0.57%
controls:0.10%
—
—
cases:0.72%
controls:0.11%
cases:3.91%
controls:0.95%
cases:5.96%
controls:2.42%
81
318
1317
13638
50
136
1348
13820
8
14
1390
13942
—
10
16
1388
13898
53
128
1301
13313
65
260
1025
10481
One hour or less
ZXE00 [2001311394]
5.6e-01
1.2e+00
1.8e+00
1.0e+50
2.2e+00
1.4e+00
1.0e+00
cases:11.16%
controls:6.71%
cases:5.29%
controls:1.71%
cases:0.57%
controls:0.09%
cases:0.64%
controls:0.00%
cases:0.79%
controls:0.09%
cases:4.28%
controls:1.07%
cases:9.08%
controls:3.50%
156
937
1242
13019
74
238
1324
13718
8
13
1390
13943
9
0
1389
13956
11
12
1387
13902
58
144
1296
13297
99
376
991
10365
Medical doctor
Z2221 [2001311556]
6.3e-01
1.4e+00
1.6e+00
—
1.8e+00
1.6e+00
1.1e+00
cases:8.73%
controls:4.86%
cases:5.08%
controls:1.27%
cases:0.86%
controls:0.18%
—
—
cases:0.93%
controls:0.16%
cases:4.65%
controls:1.00%
cases:6.70%
controls:2.36%
122
678
1276
13278
71
177
1327
13779
12
25
1386
13931
—
13
22
1385
13892
63
134
1291
13307
73
253
1017
10488
Chronic glaucoma with open ventricular angle
H40.13 [2000502335]
1.2e+00
1.4e+00
1.8e+00
—
2.4e+00
1.6e+00
1.3e+00
cases:2.15%
controls:0.66%
cases:2.00%
controls:0.51%
cases:0.36%
controls:0.06%
—
—
cases:0.72%
controls:0.06%
cases:2.36%
controls:0.50%
cases:3.94%
controls:1.15%
30
92
1368
13864
28
71
1370
13885
5
8
1393
13948
—
10
9
1388
13905
32
67
1322
13374
43
123
1047
10618
Visual field testing with Octopus automated perimetry
CS444 [2001301477]
1.3e+00
2.2e+00
—
—
—
2.6e+00
1.5e+00
cases:1.22%
controls:0.32%
cases:0.93%
controls:0.10%
—
—
—
—
—
—
cases:1.40%
controls:0.10%
cases:2.75%
controls:0.64%
17
45
1381
13911
13
14
1385
13942
—
—
—
19
14
1335
13427
30
69
1060
10672
timolol
S01ED01 [21603699]
1.1e+00
1.2e+00
1.7e+00
—
1.2e+00
1.2e+00
1.3e+00
cases:4.65%
controls:1.55%
cases:4.36%
controls:1.35%
cases:1.79%
controls:0.33%
—
—
cases:1.36%
controls:0.42%
cases:4.43%
controls:1.42%
cases:6.70%
controls:2.01%
65
217
1333
13739
61
189
1337
13767
25
46
1373
13910
—
19
58
1379
13856
60
191
1294
13250
73
216
1017
10525
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
4.9e-01
9.9e-01
2.0e+00
—
2.9e+00
9.5e-01
7.0e-01
cases:2.43%
controls:1.50%
cases:1.36%
controls:0.51%
cases:0.43%
controls:0.06%
—
—
cases:0.64%
controls:0.04%
cases:1.18%
controls:0.46%
cases:2.84%
controls:1.43%
34
209
1364
13747
19
71
1379
13885
6
8
1392
13948
—
9
5
1389
13909
16
62
1338
13379
31
154
1059
10587
Inpatient Hospital
21 [8717]
2.8e-01
6.0e-01
7.6e-01
3.8e+00
9.9e-01
5.9e-01
5.5e-01
cases:37.05%
controls:30.73%
cases:16.67%
controls:9.90%
cases:3.15%
controls:1.50%
cases:3.00%
controls:0.07%
cases:3.43%
controls:1.30%
cases:14.48%
controls:8.55%
cases:30.28%
controls:20.10%
518
4288
880
9668
233
1382
1165
12574
44
209
1354
13747
42
10
1356
13946
48
181
1350
13733
196
1149
1158
12292
330
2159
760
8582
bimatoprost
S01EE03 [21603712]
1.5e+00
1.4e+00
1.9e+00
—
1.2e+00
1.4e+00
1.3e+00
cases:1.86%
controls:0.44%
cases:1.65%
controls:0.39%
cases:0.64%
controls:0.10%
—
—
cases:0.36%
controls:0.11%
cases:1.55%
controls:0.38%
cases:2.11%
controls:0.56%
26
61
1372
13895
23
55
1375
13901
9
14
1389
13942
—
5
15
1393
13899
21
51
1333
13390
23
60
1067
10681
diclofenac
S01BC03 [21603641]
1.5e+00
2.6e+00
—
1.0e+50
—
2.2e+00
1.1e+00
cases:1.86%
controls:0.42%
cases:1.36%
controls:0.10%
—
—
cases:0.64%
controls:0.00%
—
—
cases:1.77%
controls:0.20%
cases:1.74%
controls:0.57%
26
58
1372
13898
19
14
1379
13942
—
9
0
1389
13956
—
24
27
1330
13414
19
61
1071
10680
Phakoemulsification with implantation of artificial lens in posterior chamber
CJE20 [2001301342]
5.2e-01
2.0e+00
3.0e+00
1.0e+50
1.1e+00
1.2e+00
7.0e-01
cases:8.58%
controls:5.30%
cases:9.87%
controls:1.46%
cases:2.07%
controls:0.10%
cases:0.93%
controls:0.00%
cases:0.43%
controls:0.14%
cases:4.65%
controls:1.49%
cases:11.38%
controls:6.00%
120
740
1278
13216
138
204
1260
13752
29
14
1369
13942
13
0
1385
13956
6
19
1392
13895
63
200
1291
13241
124
644
966
10097
tafluprost
S01EE05 [21603714]
8.6e-01
1.1e+00
1.5e+00
—
1.6e+00
1.2e+00
1.2e+00
cases:1.57%
controls:0.67%
cases:1.57%
controls:0.53%
cases:0.64%
controls:0.14%
—
—
cases:0.72%
controls:0.15%
cases:2.07%
controls:0.63%
cases:3.49%
controls:1.13%
22
94
1376
13862
22
74
1376
13882
9
20
1389
13936
—
10
21
1388
13893
28
85
1326
13356
38
121
1052
10620
Neurology
13 [38004458]
3.9e-01
6.3e-01
1.0e+00
2.9e+00
1.1e+00
8.7e-01
3.7e-01
cases:15.67%
controls:11.19%
cases:9.01%
controls:4.99%
cases:2.36%
controls:0.86%
cases:0.79%
controls:0.04%
cases:2.65%
controls:0.89%
cases:10.34%
controls:4.59%
cases:15.41%
controls:11.13%
219
1561
1179
12395
126
697
1272
13259
33
120
1365
13836
11
6
1387
13950
37
124
1361
13790
140
617
1214
12824
168
1196
922
9545
Sarcoidosis of lung
D86.0 [45576422]
1.6e+00
2.2e+00
—
—
—
1.8e+00
1.7e+00
cases:0.72%
controls:0.15%
cases:0.64%
controls:0.07%
—
—
—
—
—
—
cases:0.52%
controls:0.08%
cases:0.73%
controls:0.14%
10
21
1388
13935
9
10
1389
13946
—
—
—
7
11
1347
13430
8
15
1082
10726
acetazolamide; oral, parenteral
S01EC01 [21603693]
2.1e+00
—
—
—
—
2.6e+00
2.5e+00
cases:0.79%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.05%
cases:0.92%
controls:0.07%
11
14
1387
13942
—
—
—
—
9
7
1345
13434
10
8
1080
10733
Right side
ZXA00 [2001311346]
5.9e-01
1.5e+00
1.3e+00
1.0e+50
2.1e+00
1.9e+00
9.9e-01
cases:7.22%
controls:4.15%
cases:3.93%
controls:0.88%
cases:0.36%
controls:0.09%
cases:0.86%
controls:0.00%
cases:0.72%
controls:0.09%
cases:4.28%
controls:0.67%
cases:7.43%
controls:2.90%
101
579
1297
13377
55
123
1343
13833
5
13
1393
13943
12
0
1386
13956
10
12
1388
13902
58
90
1296
13351
81
311
1009
10430
Conjunctival surface anesthesia
WX100 [2001310764]
4.4e-01
1.8e+00
—
—
2.8e+00
1.6e+00
8.1e-01
cases:2.58%
controls:1.68%
cases:3.00%
controls:0.49%
—
—
—
—
cases:0.57%
controls:0.04%
cases:2.58%
controls:0.51%
cases:4.59%
controls:2.10%
36
234
1362
13722
42
69
1356
13887
—
—
8
5
1390
13909
35
69
1319
13372
50
226
1040
10515
CICLOSPORIN - yes
CICLOSPORIN-1 [2002330221]
2.0e+00
2.5e+00
—
—
—
2.5e+00
—
cases:0.43%
controls:0.06%
cases:0.50%
controls:0.04%
—
—
—
—
—
—
cases:0.44%
controls:0.04%
—
—
6
8
1392
13948
7
6
1391
13950
—
—
—
6
5
1348
13436
—
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 [45552380]
1.9e+00
2.0e+00
—
—
—
1.6e+00
1.5e+00
cases:1.29%
controls:0.20%
cases:1.22%
controls:0.16%
—
—
—
—
—
—
cases:0.89%
controls:0.18%
cases:1.47%
controls:0.34%
18
28
1380
13928
17
23
1381
13933
—
—
—
12
24
1342
13417
16
37
1074
10704
Supplier / Service Provider
OMOP5117446 [33004]
-4.8e-01
-4.3e-01
3.5e-01
—
3.0e+00
2.1e+00
2.7e+00
cases:18.03%
controls:26.15%
cases:5.51%
controls:8.20%
cases:1.14%
controls:0.81%
—
—
cases:1.00%
controls:0.05%
cases:5.76%
controls:0.74%
cases:18.81%
controls:1.56%
252
3649
1146
10307
77
1145
1321
12811
16
113
1382
13843
—
14
7
1384
13907
78
100
1276
13341
205
168
885
10573
Other healthcare associate professional
Z3229 [2001311561]
8.2e-01
1.7e+00
—
1.0e+50
—
2.7e+00
1.5e+00
cases:2.72%
controls:1.21%
cases:1.50%
controls:0.27%
—
—
cases:1.79%
controls:0.00%
—
—
cases:2.81%
controls:0.20%
cases:3.12%
controls:0.68%
38
169
1360
13787
21
37
1377
13919
—
25
0
1373
13956
—
38
27
1316
13414
34
73
1056
10668
calcium carbonate; oral
A12AA04 [21600863]
1.7e+00
1.8e+00
—
—
—
1.7e+00
1.6e+00
cases:1.57%
controls:0.29%
cases:1.00%
controls:0.17%
—
—
—
—
—
—
cases:0.96%
controls:0.17%
cases:2.02%
controls:0.43%
22
41
1376
13915
14
24
1384
13932
—
—
—
13
23
1341
13418
22
46
1068
10695
calcium carbonate
A02AC01 [21600065]
1.7e+00
1.8e+00
—
—
—
1.7e+00
1.6e+00
cases:1.57%
controls:0.29%
cases:1.00%
controls:0.17%
—
—
—
—
—
—
cases:0.96%
controls:0.17%
cases:2.02%
controls:0.43%
22
41
1376
13915
14
24
1384
13932
—
—
—
13
23
1341
13418
22
46
1068
10695
After-cataract
H26.4 [45600893]
5.1e-01
1.3e+00
2.3e+00
1.0e+50
1.7e+00
1.7e+00
1.4e+00
cases:1.86%
controls:1.12%
cases:1.57%
controls:0.45%
cases:0.50%
controls:0.05%
cases:0.79%
controls:0.00%
cases:0.36%
controls:0.06%
cases:2.29%
controls:0.42%
cases:6.61%
controls:1.69%
26
157
1372
13799
22
63
1376
13893
7
7
1391
13949
11
0
1387
13956
5
9
1393
13905
31
56
1323
13385
72
182
1018
10559
Monocytes/Leukocytes in Blood
26485-3 [3019069]
3.6e-01
5.9e-01
7.9e-01
2.8e+00
9.1e-01
5.6e-01
5.7e-01
cases:16.31%
controls:11.98%
cases:11.66%
controls:6.84%
cases:3.22%
controls:1.48%
cases:0.57%
controls:0.04%
cases:3.22%
controls:1.32%
cases:12.19%
controls:7.31%
cases:25.60%
controls:16.23%
228
1672
1170
12284
163
955
1235
13001
45
207
1353
13749
8
5
1390
13951
45
184
1353
13730
165
983
1189
12458
279
1743
811
8998
Basophils/Leukocytes in Blood
30180-4 [3022096]
3.5e-01
5.7e-01
7.5e-01
2.8e+00
8.8e-01
5.7e-01
5.7e-01
cases:16.09%
controls:11.87%
cases:11.44%
controls:6.83%
cases:3.08%
controls:1.48%
cases:0.57%
controls:0.04%
cases:3.15%
controls:1.33%
cases:12.26%
controls:7.31%
cases:25.50%
controls:16.26%
225
1656
1173
12300
160
953
1238
13003
43
206
1355
13750
8
5
1390
13951
44
185
1354
13729
166
983
1188
12458
278
1746
812
8995
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
3.5e-01
5.3e-01
7.8e-01
2.8e+00
8.7e-01
5.6e-01
5.7e-01
cases:16.45%
controls:12.21%
cases:11.52%
controls:7.09%
cases:3.22%
controls:1.50%
cases:0.57%
controls:0.04%
cases:3.22%
controls:1.37%
cases:12.56%
controls:7.56%
cases:26.06%
controls:16.62%
230
1704
1168
12252
161
990
1237
12966
45
210
1353
13746
8
5
1390
13951
45
191
1353
13723
170
1016
1184
12425
284
1785
806
8956
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
3.5e-01
5.9e-01
7.7e-01
2.6e+00
9.0e-01
5.8e-01
5.8e-01
cases:16.17%
controls:11.92%
cases:11.73%
controls:6.84%
cases:3.15%
controls:1.48%
cases:0.50%
controls:0.04%
cases:3.22%
controls:1.33%
cases:12.41%
controls:7.34%
cases:25.69%
controls:16.28%
226
1663
1172
12293
164
954
1234
13002
44
206
1354
13750
7
5
1391
13951
45
185
1353
13729
168
986
1186
12455
280
1749
810
8992
ketorolac
S01BC05 [21603643]
1.2e+00
3.5e+00
—
—
1.0e+50
—
1.8e+00
cases:1.07%
controls:0.33%
cases:1.57%
controls:0.05%
—
—
—
—
cases:0.79%
controls:0.00%
—
—
cases:1.19%
controls:0.20%
15
46
1383
13910
22
7
1376
13949
—
—
11
0
1387
13914
—
13
22
1077
10719
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.5e-01
5.7e-01
8.1e-01
2.6e+00
9.4e-01
5.6e-01
5.9e-01
cases:16.02%
controls:11.84%
cases:11.59%
controls:6.93%
cases:3.22%
controls:1.45%
cases:0.57%
controls:0.04%
cases:3.15%
controls:1.26%
cases:12.26%
controls:7.37%
cases:26.15%
controls:16.37%
224
1653
1174
12303
162
967
1236
12989
45
203
1353
13753
8
6
1390
13950
44
175
1354
13739
166
990
1188
12451
285
1758
805
8983
Visual disturbance, unspecified
H53.9 [45557475]
1.4e+00
2.8e+00
—
1.0e+50
—
2.0e+00
5.4e-01
cases:1.07%
controls:0.27%
cases:1.07%
controls:0.06%
—
—
cases:0.79%
controls:0.00%
—
—
cases:0.81%
controls:0.11%
cases:0.73%
controls:0.43%
15
37
1383
13919
15
9
1383
13947
—
11
0
1387
13956
—
11
15
1343
13426
8
46
1082
10695
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.1e-01
5.8e-01
7.9e-01
2.3e+00
9.1e-01
6.1e-01
6.0e-01
cases:17.67%
controls:12.43%
cases:12.52%
controls:7.39%
cases:3.43%
controls:1.59%
cases:0.43%
controls:0.04%
cases:3.29%
controls:1.35%
cases:13.59%
controls:7.89%
cases:28.44%
controls:17.94%
247
1735
1151
12221
175
1032
1223
12924
48
222
1350
13734
6
6
1392
13950
46
188
1352
13726
184
1060
1170
12381
310
1927
780
8814
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.7e-01
4.3e-01
1.0e+00
2.7e+00
9.2e-01
4.0e-01
4.3e-01
cases:19.38%
controls:15.52%
cases:11.44%
controls:7.78%
cases:3.00%
controls:1.08%
cases:0.64%
controls:0.04%
cases:2.65%
controls:1.07%
cases:10.49%
controls:7.31%
cases:30.37%
controls:22.10%
271
2166
1127
11790
160
1086
1238
12870
42
151
1356
13805
9
6
1389
13950
37
149
1361
13765
142
983
1212
12458
331
2374
759
8367
Basophils [#/volume] in Blood
26444-0 [3006315]
4.1e-01
5.8e-01
7.7e-01
2.3e+00
9.1e-01
6.1e-01
6.0e-01
cases:17.67%
controls:12.50%
cases:12.59%
controls:7.43%
cases:3.36%
controls:1.58%
cases:0.43%
controls:0.04%
cases:3.29%
controls:1.35%
cases:13.66%
controls:7.94%
cases:28.62%
controls:18.10%
247
1744
1151
12212
176
1037
1222
12919
47
221
1351
13735
6
6
1392
13950
46
188
1352
13726
185
1067
1169
12374
312
1944
778
8797
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.7e-01
5.7e-01
8.1e-01
2.3e+00
8.7e-01
6.0e-01
5.8e-01
cases:17.95%
controls:13.14%
cases:12.88%
controls:7.72%
cases:3.65%
controls:1.66%
cases:0.43%
controls:0.04%
cases:3.36%
controls:1.44%
cases:13.81%
controls:8.11%
cases:29.08%
controls:18.67%
251
1834
1147
12122
180
1077
1218
12879
51
231
1347
13725
6
6
1392
13950
47
200
1351
13714
187
1090
1167
12351
317
2005
773
8736
Nephrology
39 [38004479]
9.4e-01
1.1e+00
1.3e+00
—
8.4e-01
1.5e+00
1.2e+00
cases:2.58%
controls:1.02%
cases:2.29%
controls:0.75%
cases:0.93%
controls:0.24%
—
—
cases:0.64%
controls:0.28%
cases:2.95%
controls:0.70%
cases:3.76%
controls:1.16%
36
143
1362
13813
32
105
1366
13851
13
34
1385
13922
—
9
39
1389
13875
40
94
1314
13347
41
125
1049
10616
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.8e-01
5.4e-01
7.7e-01
2.3e+00
8.4e-01
5.9e-01
5.7e-01
cases:17.95%
controls:13.03%
cases:12.59%
controls:7.73%
cases:3.43%
controls:1.62%
cases:0.43%
controls:0.04%
cases:3.22%
controls:1.41%
cases:13.96%
controls:8.21%
cases:28.81%
controls:18.56%
251
1819
1147
12137
176
1079
1222
12877
48
226
1350
13730
6
6
1392
13950
45
196
1353
13718
189
1104
1165
12337
314
1993
776
8748
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
1.9e+00
—
—
—
—
2.1e+00
1.9e+00
cases:0.57%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.05%
cases:0.64%
controls:0.09%
8
12
1390
13944
—
—
—
—
6
7
1348
13434
7
10
1083
10731
Essential (primary) hypertension
I10 [45591453]
2.5e-01
3.8e-01
7.1e-01
3.3e+00
6.2e-01
3.7e-01
3.1e-01
cases:27.90%
controls:23.12%
cases:16.52%
controls:11.91%
cases:4.43%
controls:2.22%
cases:4.15%
controls:0.16%
cases:3.72%
controls:2.04%
cases:16.84%
controls:12.28%
cases:35.50%
controls:28.73%
390
3227
1008
10729
231
1662
1167
12294
62
310
1336
13646
58
22
1340
13934
52
284
1346
13630
228
1651
1126
11790
387
3086
703
7655
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
4.3e-01
8.7e-01
1.9e+00
—
3.1e+00
6.1e-01
3.6e-01
cases:2.86%
controls:1.88%
cases:1.50%
controls:0.64%
cases:0.50%
controls:0.07%
—
—
cases:0.79%
controls:0.04%
cases:1.26%
controls:0.68%
cases:2.94%
controls:2.07%
40
262
1358
13694
21
89
1377
13867
7
10
1391
13946
—
11
5
1387
13909
17
92
1337
13349
32
222
1058
10519
Benign neoplasm: Choroid
D31.3 [45566680]
—
2.1e+00
—
—
—
2.0e+00
1.8e+00
—
—
cases:0.50%
controls:0.06%
—
—
—
—
—
—
cases:0.74%
controls:0.10%
cases:1.38%
controls:0.23%
—
7
9
1391
13947
—
—
—
10
13
1344
13428
15
25
1075
10716
Headache
R51.80 [2000503603]
4.4e-01
8.6e-01
2.7e+00
—
2.3e+00
7.2e-01
3.0e-01
cases:3.00%
controls:1.95%
cases:1.43%
controls:0.61%
cases:0.64%
controls:0.04%
—
—
cases:0.43%
controls:0.04%
cases:1.18%
controls:0.58%
cases:3.03%
controls:2.26%
42
272
1356
13684
20
85
1378
13871
9
6
1389
13950
—
6
6
1392
13908
16
78
1338
13363
33
243
1057
10498
prednisolone; oral, parenteral
H02AB06 [21602734]
4.3e-01
5.6e-01
7.9e-01
2.3e+00
9.0e-01
3.9e-01
4.8e-01
cases:17.60%
controls:12.23%
cases:9.44%
controls:5.60%
cases:2.07%
controls:0.95%
cases:0.43%
controls:0.04%
cases:2.43%
controls:1.01%
cases:8.20%
controls:5.68%
cases:19.27%
controls:12.89%
246
1707
1152
12249
132
781
1266
13175
29
133
1369
13823
6
6
1392
13950
34
140
1364
13774
111
764
1243
12677
210
1385
880
9356
prednisolone
A07EA01 [21600653]
4.2e-01
5.6e-01
7.9e-01
2.3e+00
9.0e-01
4.0e-01
4.7e-01
cases:17.60%
controls:12.30%
cases:9.44%
controls:5.62%
cases:2.07%
controls:0.95%
cases:0.43%
controls:0.04%
cases:2.43%
controls:1.01%
cases:8.27%
controls:5.68%
cases:19.36%
controls:13.01%
246
1717
1152
12239
132
785
1266
13171
29
133
1369
13823
6
6
1392
13950
34
140
1364
13774
112
764
1242
12677
211
1397
879
9344
Rheumatology
66 [38004491]
7.1e-01
1.0e+00
1.2e+00
—
1.1e+00
1.0e+00
7.9e-01
cases:7.08%
controls:3.60%
cases:5.58%
controls:2.07%
cases:1.43%
controls:0.45%
—
—
cases:1.36%
controls:0.44%
cases:5.61%
controls:2.13%
cases:8.07%
controls:3.85%
99
502
1299
13454
78
289
1320
13667
20
63
1378
13893
—
19
61
1379
13853
76
286
1278
13155
88
413
1002
10328
tacrolimus; oral, parenteral
L04AD02 [21603925]
2.1e+00
1.9e+00
—
—
—
1.9e+00
1.4e+00
cases:0.50%
controls:0.06%
cases:0.57%
controls:0.09%
—
—
—
—
—
—
cases:0.66%
controls:0.10%
cases:0.55%
controls:0.13%
7
9
1391
13947
8
12
1390
13944
—
—
—
9
14
1345
13427
6
14
1084
10727
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
1.6e+00
1.4e+00
—
—
—
1.9e+00
2.3e+00
cases:0.86%
controls:0.17%
cases:0.57%
controls:0.14%
—
—
—
—
—
—
cases:0.66%
controls:0.10%
cases:1.01%
controls:0.10%
12
24
1386
13932
8
20
1390
13936
—
—
—
9
14
1345
13427
11
11
1079
10730
Glaucoma secondary to other eye disorders
H40.5 [45571978]
—
—
—
—
—
2.8e+00
3.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.04%
cases:1.10%
controls:0.06%
—
—
—
—
—
8
5
1346
13436
12
6
1078
10735
travoprost
S01EE04 [21603713]
1.1e+00
1.2e+00
2.3e+00
—
—
7.1e-01
1.1e+00
cases:1.65%
controls:0.54%
cases:1.29%
controls:0.41%
cases:0.50%
controls:0.05%
—
—
—
—
cases:0.89%
controls:0.44%
cases:1.83%
controls:0.60%
23
76
1375
13880
18
57
1380
13899
7
7
1391
13949
—
—
12
59
1342
13382
20
64
1070
10677
Intravenous
ZX120 [2001311495]
7.3e-01
1.4e+00
1.5e+00
—
1.4e+00
9.9e-01
1.1e+00
cases:2.50%
controls:1.23%
cases:1.57%
controls:0.39%
cases:0.64%
controls:0.14%
—
—
cases:0.43%
controls:0.11%
cases:1.26%
controls:0.47%
cases:3.30%
controls:1.14%
35
171
1363
13785
22
55
1376
13901
9
20
1389
13936
—
6
15
1392
13899
17
63
1337
13378
36
122
1054
10619
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
5.7e-01
9.8e-01
—
—
2.2e+00
1.3e+00
6.7e-01
cases:4.65%
controls:2.69%
cases:2.58%
controls:0.98%
—
—
—
—
cases:0.64%
controls:0.07%
cases:2.81%
controls:0.82%
cases:6.15%
controls:3.25%
65
376
1333
13580
36
137
1362
13819
—
—
9
10
1389
13904
38
110
1316
13331
67
349
1023
10392
alfacalcidol; oral, parenteral
A11CC03 [21600818]
1.3e+00
1.3e+00
—
—
—
1.6e+00
1.4e+00
cases:1.14%
controls:0.31%
cases:1.00%
controls:0.28%
—
—
—
—
—
—
cases:1.18%
controls:0.25%
cases:1.47%
controls:0.35%
16
43
1382
13913
14
39
1384
13917
—
—
—
16
33
1338
13408
16
38
1074
10703
Senile incipient cataract
H25.0 [45576699]
9.0e-01
1.9e+00
—
1.0e+50
—
1.8e+00
1.1e+00
cases:1.36%
controls:0.56%
cases:1.36%
controls:0.21%
—
—
cases:1.07%
controls:0.00%
—
—
cases:1.40%
controls:0.24%
cases:2.11%
controls:0.74%
19
78
1379
13878
19
30
1379
13926
—
15
0
1383
13956
—
19
32
1335
13409
23
80
1067
10661
Assessment of vision
XCW10 [2001301503]
—
—
—
—
—
3.5e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.04%
cases:1.93%
controls:0.24%
—
—
—
—
—
19
6
1335
13435
21
26
1069
10715
Scheduled procedure
ZXD10 [2001311387]
4.8e-01
1.0e+00
—
1.0e+50
1.7e+00
1.3e+00
9.4e-01
cases:10.09%
controls:6.48%
cases:4.36%
controls:1.58%
—
—
cases:0.50%
controls:0.00%
cases:0.64%
controls:0.11%
cases:3.84%
controls:1.09%
cases:7.52%
controls:3.07%
141
905
1257
13051
61
221
1337
13735
—
7
0
1391
13956
9
16
1389
13898
52
147
1302
13294
82
330
1008
10411
Hemodialysis
TK800 [2001305768]
1.5e+00
1.5e+00
2.3e+00
—
—
1.4e+00
1.7e+00
cases:0.86%
controls:0.20%
cases:0.50%
controls:0.11%
cases:0.43%
controls:0.04%
—
—
—
—
cases:0.37%
controls:0.09%
cases:0.92%
controls:0.17%
12
28
1386
13928
7
16
1391
13940
6
6
1392
13950
—
—
5
12
1349
13429
10
18
1080
10723
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.2e-01
4.1e-01
7.1e-01
2.4e+00
9.4e-01
3.5e-01
4.0e-01
cases:27.25%
controls:23.12%
cases:16.88%
controls:11.88%
cases:3.43%
controls:1.71%
cases:0.79%
controls:0.07%
cases:3.86%
controls:1.55%
cases:16.17%
controls:11.93%
cases:39.72%
controls:30.63%
381
3227
1017
10729
236
1658
1162
12298
48
239
1350
13717
11
10
1387
13946
54
216
1344
13698
219
1603
1135
11838
433
3290
657
7451
Vitreous haemorrhage
H43.1 [45543053]
2.7e+00
—
1.0e+50
1.0e+50
—
—
2.7e+00
cases:1.50%
controls:0.10%
—
—
cases:0.43%
controls:0.00%
cases:0.72%
controls:0.00%
—
—
—
—
cases:1.74%
controls:0.12%
21
14
1377
13942
—
6
0
1392
13956
10
0
1388
13956
—
—
19
13
1071
10728
insulin aspart; parenteral
A10AB05 [21600719]
1.1e+00
1.0e+00
9.6e-01
—
1.4e+00
1.1e+00
7.8e-01
cases:4.86%
controls:1.71%
cases:4.36%
controls:1.62%
cases:1.00%
controls:0.39%
—
—
cases:1.43%
controls:0.36%
cases:4.80%
controls:1.70%
cases:5.60%
controls:2.64%
68
238
1330
13718
61
226
1337
13730
14
54
1384
13902
—
20
50
1378
13864
65
229
1289
13212
61
284
1029
10457
Emergency Medicine
93 [38004510]
9.4e-02
2.6e-01
1.1e+00
3.1e+00
8.7e-01
2.0e-01
2.6e-01
cases:18.38%
controls:17.01%
cases:11.16%
controls:8.86%
cases:3.79%
controls:1.33%
cases:1.57%
controls:0.07%
cases:2.65%
controls:1.12%
cases:11.45%
controls:9.60%
cases:32.29%
controls:26.93%
257
2374
1141
11582
156
1236
1242
12720
53
185
1345
13771
22
10
1376
13946
37
156
1361
13758
155
1290
1199
12151
352
2893
738
7848
insulin aspart; parenteral
A10AD05 [21600733]
1.1e+00
1.0e+00
9.6e-01
—
1.4e+00
1.0e+00
7.6e-01
cases:4.94%
controls:1.72%
cases:4.36%
controls:1.64%
cases:1.00%
controls:0.39%
—
—
cases:1.43%
controls:0.37%
cases:4.80%
controls:1.74%
cases:5.60%
controls:2.70%
69
240
1329
13716
61
229
1337
13727
14
54
1384
13902
—
20
51
1378
13863
65
234
1289
13207
61
290
1029
10451
Infectious Disease
44 [38004484]
6.2e-01
1.2e+00
1.3e+00
—
1.8e+00
9.8e-01
6.6e-01
cases:3.00%
controls:1.63%
cases:2.15%
controls:0.65%
cases:0.43%
controls:0.12%
—
—
cases:0.64%
controls:0.11%
cases:1.92%
controls:0.73%
cases:3.67%
controls:1.94%
42
228
1356
13728
30
91
1368
13865
6
17
1392
13939
—
9
15
1389
13899
26
98
1328
13343
40
208
1050
10533
Visual field defects
H53.4 [45557469]
9.9e-01
2.7e+00
—
1.0e+50
—
2.6e+00
1.4e+00
cases:0.50%
controls:0.19%
cases:0.72%
controls:0.05%
—
—
cases:0.43%
controls:0.00%
—
—
cases:0.59%
controls:0.04%
cases:0.73%
controls:0.19%
7
26
1391
13930
10
7
1388
13949
—
6
0
1392
13956
—
8
6
1346
13435
8
20
1082
10721
Teaching
WZC30 [2001310891]
4.3e-01
7.9e-01
1.8e+00
—
1.7e+00
8.7e-01
4.8e-01
cases:3.08%
controls:2.01%
cases:2.07%
controls:0.95%
cases:0.72%
controls:0.11%
—
—
cases:0.64%
controls:0.11%
cases:2.44%
controls:1.03%
cases:5.05%
controls:3.18%
43
281
1355
13675
29
133
1369
13823
10
16
1388
13940
—
9
16
1389
13898
33
139
1321
13302
55
342
1035
10399
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
6.4e-01
1.8e+00
—
—
—
2.3e+00
1.1e+00
cases:1.29%
controls:0.68%
cases:0.93%
controls:0.16%
—
—
—
—
—
—
cases:1.18%
controls:0.12%
cases:1.74%
controls:0.59%
18
95
1380
13861
13
22
1385
13934
—
—
—
16
16
1338
13425
19
63
1071
10678
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.6e-01
5.5e-01
6.4e-01
1.7e+00
7.4e-01
5.5e-01
6.4e-01
cases:20.67%
controls:15.33%
cases:14.95%
controls:9.19%
cases:4.43%
controls:2.39%
cases:0.57%
controls:0.11%
cases:4.15%
controls:2.02%
cases:15.51%
controls:9.55%
cases:32.84%
controls:20.47%
289
2140
1109
11816
209
1283
1189
12673
62
333
1336
13623
8
15
1390
13941
58
281
1340
13633
210
1284
1144
12157
358
2199
732
8542
Case Management Agency
251B00000X [38004193]
1.3e-01
2.2e-01
5.2e-01
3.5e+00
5.7e-01
3.0e-01
1.7e-01
cases:76.39%
controls:74.06%
cases:71.89%
controls:67.14%
cases:40.13%
controls:28.48%
cases:41.13%
controls:2.01%
cases:41.27%
controls:28.52%
cases:75.48%
controls:69.62%
cases:86.51%
controls:84.41%
1068
10336
330
3620
1005
9370
393
4586
561
3975
837
9981
575
281
823
13675
577
3968
821
9946
1022
9357
332
4084
943
9066
147
1675
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
4.9e-01
1.6e+00
—
—
—
2.2e+00
1.3e+00
cases:1.50%
controls:0.92%
cases:1.14%
controls:0.23%
—
—
—
—
—
—
cases:1.18%
controls:0.13%
cases:2.20%
controls:0.63%
21
129
1377
13827
16
32
1382
13924
—
—
—
16
18
1338
13423
24
68
1066
10673
Visual field testing with Goldmann perimetry
CS424 [2001301475]
2.5e+00
—
—
—
—
—
2.4e+00
cases:0.43%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.07%
6
5
1392
13951
—
—
—
—
—
8
7
1082
10734
insulin (human); parenteral
A10AB01 [21600715]
1.2e+00
1.2e+00
—
—
—
1.3e+00
1.2e+00
cases:1.43%
controls:0.43%
cases:0.93%
controls:0.29%
—
—
—
—
—
—
cases:1.03%
controls:0.28%
cases:1.28%
controls:0.41%
20
60
1378
13896
13
40
1385
13916
—
—
—
14
37
1340
13404
14
44
1076
10697
Type 2 diabetes mellitus, with ophthalmic complications
E11.3 [45591028]
1.6e+00
—
—
—
—
2.0e+00
1.3e+00
cases:0.93%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.11%
cases:1.19%
controls:0.33%
13
27
1385
13929
—
—
—
—
11
15
1343
13426
13
35
1077
10706
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.0e+00
1.4e+00
—
—
—
1.3e+00
1.0e+00
cases:1.29%
controls:0.47%
cases:1.07%
controls:0.26%
—
—
—
—
—
—
cases:0.81%
controls:0.22%
cases:1.83%
controls:0.67%
18
66
1380
13890
15
36
1383
13920
—
—
—
11
29
1343
13412
20
72
1070
10669
Low pressure glaucoma
H40.11 [2000502333]
1.2e+00
2.0e+00
—
1.0e+50
—
1.5e+00
1.3e+00
cases:0.72%
controls:0.21%
cases:1.07%
controls:0.15%
—
—
cases:0.50%
controls:0.00%
—
—
cases:0.96%
controls:0.21%
cases:1.74%
controls:0.49%
10
30
1388
13926
15
21
1383
13935
—
7
0
1391
13956
—
13
28
1341
13413
19
53
1071
10688
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
3.9e-01
8.0e-01
9.9e-01
—
1.3e+00
7.5e-01
5.3e-01
cases:9.08%
controls:6.31%
cases:6.15%
controls:2.87%
cases:1.07%
controls:0.40%
—
—
cases:1.57%
controls:0.45%
cases:5.61%
controls:2.73%
cases:12.66%
controls:7.85%
127
881
1271
13075
86
400
1312
13556
15
56
1383
13900
—
22
63
1376
13851
76
367
1278
13074
138
843
952
9898
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
6.7e-01
7.7e-01
1.3e+00
—
1.1e+00
1.1e+00
7.2e-01
cases:3.72%
controls:1.94%
cases:2.43%
controls:1.14%
cases:0.86%
controls:0.23%
—
—
cases:0.64%
controls:0.21%
cases:3.18%
controls:1.07%
cases:5.23%
controls:2.63%
52
271
1346
13685
34
159
1364
13797
12
32
1386
13924
—
9
29
1389
13885
43
144
1311
13297
57
282
1033
10459
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6.4e-01
1.5e+00
—
—
—
1.9e+00
1.1e+00
cases:1.79%
controls:0.95%
cases:1.22%
controls:0.29%
—
—
—
—
—
—
cases:1.40%
controls:0.22%
cases:2.75%
controls:0.91%
25
133
1373
13823
17
40
1381
13916
—
—
—
19
29
1335
13412
30
98
1060
10643
pH of Serum or Plasma
2753-2 [3018418]
4.0e-01
5.4e-01
1.0e+00
—
9.6e-01
7.9e-01
7.1e-01
cases:10.30%
controls:7.12%
cases:6.58%
controls:3.93%
cases:1.93%
controls:0.70%
—
—
cases:1.72%
controls:0.66%
cases:8.35%
controls:3.98%
cases:18.90%
controls:10.24%
144
993
1254
12963
92
548
1306
13408
27
98
1371
13858
—
24
92
1374
13822
113
535
1241
12906
206
1100
884
9641
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
3.5e-01
3.9e-01
1.7e+00
—
1.8e+00
9.1e-01
3.2e-01
cases:3.51%
controls:2.49%
cases:1.65%
controls:1.12%
cases:0.64%
controls:0.12%
—
—
cases:0.57%
controls:0.09%
cases:2.81%
controls:1.15%
cases:6.42%
controls:4.76%
49
347
1349
13609
23
157
1375
13799
9
17
1389
13939
—
8
13
1390
13901
38
155
1316
13286
70
511
1020
10230
Multiple sclerosis
G35 [45571794]
1.3e+00
1.5e+00
1.9e+00
—
1.7e+00
1.6e+00
1.2e+00
cases:0.93%
controls:0.27%
cases:0.93%
controls:0.21%
cases:0.43%
controls:0.06%
—
—
cases:0.43%
controls:0.08%
cases:1.03%
controls:0.21%
cases:0.92%
controls:0.27%
13
37
1385
13919
13
29
1385
13927
6
9
1392
13947
—
6
11
1392
13903
14
28
1340
13413
10
29
1080
10712
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.9e-01
4.3e-01
6.5e-01
1.6e+00
6.7e-01
3.8e-01
2.9e-01
cases:35.55%
controls:29.17%
cases:32.47%
controls:23.77%
cases:9.73%
controls:5.30%
cases:1.50%
controls:0.30%
cases:9.23%
controls:4.92%
cases:32.20%
controls:24.54%
cases:51.38%
controls:44.13%
497
4071
901
9885
454
3318
944
10638
136
740
1262
13216
21
42
1377
13914
129
685
1269
13229
436
3298
918
10143
560
4740
530
6001
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.7e-01
3.3e-01
6.7e-01
1.8e+00
7.4e-01
4.0e-01
3.8e-01
cases:40.34%
controls:36.39%
cases:29.69%
controls:23.27%
cases:9.01%
controls:4.83%
cases:1.86%
controls:0.31%
cases:8.58%
controls:4.28%
cases:31.61%
controls:23.62%
cases:58.44%
controls:48.99%
564
5079
834
8877
415
3248
983
10708
126
674
1272
13282
26
43
1372
13913
120
595
1278
13319
428
3175
926
10266
637
5262
453
5479
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
5.4e-01
9.2e-01
7.4e-01
—
1.3e+00
8.4e-01
7.8e-01
cases:4.86%
controls:2.89%
cases:3.58%
controls:1.45%
cases:0.64%
controls:0.31%
—
—
cases:1.00%
controls:0.29%
cases:3.47%
controls:1.53%
cases:8.26%
controls:3.97%
68
403
1330
13553
50
203
1348
13753
9
43
1389
13913
—
14
40
1384
13874
47
206
1307
13235
90
426
1000
10315
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
7.2e-01
1.7e+00
—
—
—
1.7e+00
9.3e-01
cases:1.36%
controls:0.67%
cases:1.07%
controls:0.20%
—
—
—
—
—
—
cases:1.18%
controls:0.22%
cases:1.83%
controls:0.74%
19
93
1379
13863
15
28
1383
13928
—
—
—
16
29
1338
13412
20
79
1070
10662
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.6e-01
6.5e-01
9.9e-01
—
1.0e+00
6.4e-01
6.6e-01
cases:11.23%
controls:8.08%
cases:8.51%
controls:4.64%
cases:2.65%
controls:1.00%
—
—
cases:2.72%
controls:1.02%
cases:9.16%
controls:5.07%
cases:18.81%
controls:10.66%
157
1128
1241
12828
119
648
1279
13308
37
140
1361
13816
—
38
142
1360
13772
124
681
1230
12760
205
1145
885
9596
Visual disturbance other
F05 [2002000403]
6.9e-01
2.9e+00
1.0e+50
—
—
—
1.4e+00
cases:0.43%
controls:0.21%
cases:1.00%
controls:0.06%
cases:0.72%
controls:0.00%
—
—
—
—
—
—
cases:1.10%
controls:0.27%
6
30
1392
13926
14
8
1384
13948
10
0
1388
13956
—
—
—
12
29
1078
10712
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
6.3e-01
6.9e-01
1.1e+00
—
1.6e+00
6.9e-01
6.4e-01
cases:4.08%
controls:2.22%
cases:2.50%
controls:1.28%
cases:0.79%
controls:0.27%
—
—
cases:1.29%
controls:0.27%
cases:2.66%
controls:1.35%
cases:6.70%
controls:3.63%
57
310
1341
13646
35
178
1363
13778
11
37
1387
13919
—
18
38
1380
13876
36
181
1318
13260
73
390
1017
10351
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
6.7e-01
1.2e+00
—
—
—
1.9e+00
1.0e+00
cases:1.36%
controls:0.70%
cases:1.00%
controls:0.29%
—
—
—
—
—
—
cases:1.18%
controls:0.17%
cases:1.83%
controls:0.66%
19
98
1379
13858
14
41
1384
13915
—
—
—
16
23
1338
13418
20
71
1070
10670
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
6.8e-01
1.6e+00
—
—
—
1.7e+00
9.0e-01
cases:1.36%
controls:0.70%
cases:1.07%
controls:0.22%
—
—
—
—
—
—
cases:1.18%
controls:0.22%
cases:1.83%
controls:0.75%
19
97
1379
13859
15
31
1383
13925
—
—
—
16
29
1338
13412
20
81
1070
10660
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
4.3e-01
8.7e-01
—
—
1.7e+00
8.7e-01
7.0e-01
cases:3.58%
controls:2.36%
cases:2.07%
controls:0.88%
—
—
—
—
cases:0.57%
controls:0.10%
cases:1.85%
controls:0.78%
cases:5.60%
controls:2.85%
50
330
1348
13626
29
123
1369
13833
—
—
8
14
1390
13900
25
105
1329
13336
61
306
1029
10435
Internal Medicine
11 [38004456]
4.6e-01
5.8e-01
8.9e-01
—
9.8e-01
6.7e-01
5.8e-01
cases:30.54%
controls:21.77%
cases:13.95%
controls:8.33%
cases:3.08%
controls:1.28%
—
—
cases:3.29%
controls:1.26%
cases:14.03%
controls:7.71%
cases:30.37%
controls:19.56%
427
3038
971
10918
195
1162
1203
12794
43
179
1355
13777
—
46
175
1352
13739
190
1036
1164
12405
331
2101
759
8640
Thrombin time
3243-3 [3036489]
5.3e-01
1.2e+00
—
—
—
2.0e+00
9.3e-01
cases:1.43%
controls:0.85%
cases:1.14%
controls:0.34%
—
—
—
—
—
—
cases:1.40%
controls:0.19%
cases:2.02%
controls:0.81%
20
118
1378
13838
16
47
1382
13909
—
—
—
19
26
1335
13415
22
87
1068
10654
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
6.0e-01
9.8e-01
1.3e+00
—
1.6e+00
8.8e-01
3.0e-01
cases:3.00%
controls:1.68%
cases:2.22%
controls:0.85%
cases:0.50%
controls:0.14%
—
—
cases:0.64%
controls:0.13%
cases:2.29%
controls:0.97%
cases:5.50%
controls:4.12%
42
234
1356
13722
31
118
1367
13838
7
19
1391
13937
—
9
18
1389
13896
31
130
1323
13311
60
443
1030
10298
Pure hypercholesterolaemia
E78.01 [2000501514]
2.8e-01
7.6e-02
1.1e+00
3.0e+00
3.5e-01
2.0e-01
1.9e-01
cases:5.58%
controls:4.28%
cases:2.36%
controls:2.19%
cases:1.14%
controls:0.40%
cases:1.00%
controls:0.05%
cases:0.50%
controls:0.35%
cases:3.18%
controls:2.61%
cases:8.26%
controls:6.95%
78
597
1320
13359
33
306
1365
13650
16
56
1382
13900
14
7
1384
13949
7
49
1391
13865
43
351
1311
13090
90
746
1000
9995
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
9.7e-01
1.4e+00
—
—
—
2.0e+00
2.0e+00
cases:0.36%
controls:0.14%
cases:0.36%
controls:0.09%
—
—
—
—
—
—
cases:0.44%
controls:0.06%
cases:1.19%
controls:0.16%
5
19
1393
13937
5
12
1393
13944
—
—
—
6
8
1348
13433
13
17
1077
10724
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
2.6e-01
1.9e+00
—
—
—
2.1e+00
1.0e+00
cases:0.50%
controls:0.39%
cases:0.64%
controls:0.09%
—
—
—
—
—
—
cases:0.59%
controls:0.07%
cases:1.01%
controls:0.36%
7
54
1391
13902
9
13
1389
13943
—
—
—
8
10
1346
13431
11
39
1079
10702
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.5e-01
2.9e-01
5.7e-01
1.8e+00
7.4e-01
2.7e-01
2.7e-01
cases:44.28%
controls:40.63%
cases:38.77%
controls:32.09%
cases:10.66%
controls:6.33%
cases:1.86%
controls:0.30%
cases:11.59%
controls:5.88%
cases:39.00%
controls:32.88%
cases:65.14%
controls:58.81%
619
5670
779
8286
542
4479
856
9477
149
883
1249
13073
26
42
1372
13914
162
818
1236
13096
528
4420
826
9021
710
6317
380
4424
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
5.9e-01
6.7e-01
8.3e-01
—
1.6e+00
6.4e-01
4.9e-01
cases:5.36%
controls:3.04%
cases:3.65%
controls:1.90%
cases:0.79%
controls:0.34%
—
—
cases:0.86%
controls:0.18%
cases:3.84%
controls:2.05%
cases:10.09%
controls:6.41%
75
424
1323
13532
51
265
1347
13691
11
48
1387
13908
—
12
25
1386
13889
52
276
1302
13165
110
689
980
10052
Pharmacy visit
OMOP4822462 [581458]
4.4e-01
7.7e-01
4.9e-01
1.4e+00
5.9e-01
7.5e-01
6.2e-01
cases:96.78%
controls:95.07%
cases:93.92%
controls:87.73%
cases:64.23%
controls:52.48%
cases:10.37%
controls:2.84%
cases:66.60%
controls:52.59%
cases:94.02%
controls:88.12%
cases:97.80%
controls:95.99%
1353
13268
45
688
1313
12244
85
1712
898
7324
500
6632
145
396
1253
13560
931
7318
467
6596
1273
11844
81
1597
1066
10310
24
431
Varicella zoster virus Ab [Titer] in Serum
21594-7 [3014148]
8.0e-01
—
1.0e+50
—
1.0e+50
2.3e+00
1.7e+00
cases:0.43%
controls:0.19%
—
—
cases:0.43%
controls:0.00%
—
—
cases:0.43%
controls:0.00%
cases:0.52%
controls:0.05%
cases:0.73%
controls:0.14%
6
27
1392
13929
—
6
0
1392
13956
—
6
0
1392
13914
7
7
1347
13434
8
15
1082
10726
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.4e-01
2.8e-01
5.6e-01
1.8e+00
7.4e-01
2.7e-01
2.6e-01
cases:44.28%
controls:40.96%
cases:38.84%
controls:32.51%
cases:10.80%
controls:6.45%
cases:1.86%
controls:0.31%
cases:11.73%
controls:5.97%
cases:39.51%
controls:33.30%
cases:65.32%
controls:59.13%
619
5717
779
8239
543
4537
855
9419
151
900
1247
13056
26
43
1372
13913
164
830
1234
13084
535
4476
819
8965
712
6351
378
4390
Sedation and analgesia
WX002 [2001310758]
5.8e-01
1.3e+00
—
—
1.5e+00
1.1e+00
8.6e-01
cases:5.72%
controls:3.28%
cases:3.15%
controls:0.87%
—
—
—
—
cases:0.50%
controls:0.11%
cases:2.14%
controls:0.69%
cases:5.50%
controls:2.41%
80
458
1318
13498
44
121
1354
13835
—
—
7
15
1391
13899
29
93
1325
13348
60
259
1030
10482
Other specified coagulation defects
D68.8 [45532994]
1.9e+00
—
—
—
—
1.8e+00
2.0e+00
cases:0.50%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.37%
controls:0.06%
cases:0.55%
controls:0.07%
7
11
1391
13945
—
—
—
—
5
8
1349
13433
6
8
1084
10733
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
6.0e-01
1.3e+00
—
—
—
1.4e+00
1.1e+00
cases:1.22%
controls:0.67%
cases:0.93%
controls:0.26%
—
—
—
—
—
—
cases:0.89%
controls:0.22%
cases:2.02%
controls:0.65%
17
94
1381
13862
13
36
1385
13920
—
—
—
12
29
1342
13412
22
70
1068
10671
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.4e-01
4.0e-01
6.1e-01
1.5e+00
6.8e-01
3.8e-01
2.0e-01
cases:40.63%
controls:34.88%
cases:35.69%
controls:27.05%
cases:10.16%
controls:5.80%
cases:1.43%
controls:0.32%
cases:10.52%
controls:5.62%
cases:35.89%
controls:27.71%
cases:53.39%
controls:48.51%
568
4868
830
9088
499
3775
899
10181
142
810
1256
13146
20
44
1378
13912
147
782
1251
13132
486
3724
868
9717
582
5210
508
5531
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
8.1e-01
2.0e+00
—
—
—
1.8e+00
1.1e+00
cases:0.79%
controls:0.35%
cases:0.79%
controls:0.11%
—
—
—
—
—
—
cases:0.52%
controls:0.09%
cases:0.92%
controls:0.32%
11
49
1387
13907
11
15
1387
13941
—
—
—
7
12
1347
13429
10
34
1080
10707
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
3.9e-01
7.2e-01
—
1.0e+50
—
2.2e+00
1.6e+00
cases:1.14%
controls:0.78%
cases:0.50%
controls:0.24%
—
—
cases:0.43%
controls:0.00%
—
—
cases:1.40%
controls:0.16%
cases:2.29%
controls:0.48%
16
109
1382
13847
7
34
1391
13922
—
6
0
1392
13956
—
19
22
1335
13419
25
52
1065
10689
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
1.0e+00
1.4e+00
—
—
—
2.0e+00
1.7e+00
cases:0.36%
controls:0.13%
cases:0.36%
controls:0.09%
—
—
—
—
—
—
cases:0.44%
controls:0.06%
cases:1.01%
controls:0.19%
5
18
1393
13938
5
12
1393
13944
—
—
—
6
8
1348
13433
11
20
1079
10721
Other specified counselling
Z71.8 [45581061]
5.4e-01
5.4e-01
8.6e-01
—
1.5e+00
6.3e-01
4.8e-01
cases:7.65%
controls:4.59%
cases:4.15%
controls:2.46%
cases:0.64%
controls:0.27%
—
—
cases:1.50%
controls:0.34%
cases:5.17%
controls:2.82%
cases:13.49%
controls:8.80%
107
641
1291
13315
58
343
1340
13613
9
38
1389
13918
—
21
47
1377
13867
70
379
1284
13062
147
945
943
9796
latanoprost
S01EE01 [21603710]
8.6e-01
1.0e+00
8.6e-01
—
9.9e-01
9.5e-01
8.6e-01
cases:3.65%
controls:1.58%
cases:3.65%
controls:1.35%
cases:0.86%
controls:0.37%
—
—
cases:1.00%
controls:0.37%
cases:3.55%
controls:1.41%
cases:4.13%
controls:1.80%
51
220
1347
13736
51
189
1347
13767
12
51
1386
13905
—
14
52
1384
13862
48
189
1306
13252
45
193
1045
10548
Laser discission of secondary cataract
CJB10 [2001301313]
5.2e-01
1.1e+00
—
—
—
2.1e+00
1.6e+00
cases:1.72%
controls:1.02%
cases:0.86%
controls:0.29%
—
—
—
—
—
—
cases:2.36%
controls:0.29%
cases:5.50%
controls:1.22%
24
143
1374
13813
12
41
1386
13915
—
—
—
32
39
1322
13402
60
131
1030
10610
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 [3012220]
9.8e-01
1.2e+00
1.0e+50
—
1.0e+50
2.0e+00
1.6e+00
cases:0.57%
controls:0.21%
cases:0.43%
controls:0.13%
cases:0.43%
controls:0.00%
—
—
cases:0.43%
controls:0.00%
cases:0.52%
controls:0.07%
cases:0.73%
controls:0.15%
8
30
1390
13926
6
18
1392
13938
6
0
1392
13956
—
6
0
1392
13914
7
9
1347
13432
8
16
1082
10725
Genetic counselling
Z31.5 [45590715]
2.4e-01
7.8e-01
—
—
—
2.2e+00
1.4e+00
cases:0.86%
controls:0.67%
cases:0.50%
controls:0.23%
—
—
—
—
—
—
cases:1.03%
controls:0.11%
cases:1.83%
controls:0.46%
12
94
1386
13862
7
32
1391
13924
—
—
—
14
15
1340
13426
20
49
1070
10692
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
6.6e-01
1.1e+00
—
—
—
1.2e+00
7.4e-01
cases:2.36%
controls:1.23%
cases:1.14%
controls:0.40%
—
—
—
—
—
—
cases:1.26%
controls:0.39%
cases:3.03%
controls:1.46%
33
172
1365
13784
16
56
1382
13900
—
—
—
17
53
1337
13388
33
157
1057
10584
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.4e-01
2.8e-01
5.4e-01
1.5e+00
6.7e-01
2.9e-01
3.0e-01
cases:47.28%
controls:43.74%
cases:43.49%
controls:36.75%
cases:12.88%
controls:7.90%
cases:1.93%
controls:0.42%
cases:13.38%
controls:7.30%
cases:44.68%
controls:37.79%
cases:69.63%
controls:62.96%
661
6105
737
7851
608
5129
790
8827
180
1103
1218
12853
27
59
1371
13897
187
1016
1211
12898
605
5079
749
8362
759
6763
331
3978
Hip joint ultrasound examination
NF1AE [2001307895]
8.8e-01
—
—
—
—
2.0e+00
1.6e+00
cases:0.86%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.06%
cases:0.92%
controls:0.19%
12
50
1386
13906
—
—
—
—
6
8
1348
13433
10
20
1080
10721
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.1e-01
5.1e-01
8.0e-01
—
7.5e-01
5.5e-01
5.8e-01
cases:15.67%
controls:11.00%
cases:9.44%
controls:5.90%
cases:2.15%
controls:0.97%
—
—
cases:1.86%
controls:0.88%
cases:10.12%
controls:6.08%
cases:25.50%
controls:16.14%
219
1535
1179
12421
132
824
1266
13132
30
136
1368
13820
—
26
123
1372
13791
137
817
1217
12624
278
1734
812
9007
Atherosclerotic heart disease
I25.1 [45596196]
1.4e-01
8.4e-02
7.0e-01
3.2e+00
6.0e-01
4.2e-01
3.6e-01
cases:6.44%
controls:5.67%
cases:3.43%
controls:3.17%
cases:1.22%
controls:0.61%
cases:0.86%
controls:0.04%
cases:0.93%
controls:0.51%
cases:5.02%
controls:3.36%
cases:10.64%
controls:7.70%
90
791
1308
13165
48
442
1350
13514
17
85
1381
13871
12
5
1386
13951
13
71
1385
13843
68
451
1286
12990
116
827
974
9914
Other visual field testing
CS494 [2001301478]
8.9e-01
1.1e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:0.72%
controls:0.29%
cases:0.57%
controls:0.19%
—
—
cases:0.36%
controls:0.00%
—
—
cases:1.40%
controls:0.16%
cases:1.83%
controls:0.49%
10
41
1388
13915
8
26
1390
13930
—
5
0
1393
13956
—
19
21
1335
13420
20
53
1070
10688
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
4.5e-01
—
—
—
—
2.2e+00
1.3e+00
cases:0.79%
controls:0.50%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.07%
cases:1.01%
controls:0.27%
11
70
1387
13886
—
—
—
—
8
9
1346
13432
11
29
1079
10712
Platelets [#/volume] in Blood
26515-7 [3007461]
1.1e-01
2.9e-01
4.8e-01
1.6e+00
5.9e-01
2.9e-01
2.3e-01
cases:49.86%
controls:47.13%
cases:46.92%
controls:39.73%
cases:13.73%
controls:8.96%
cases:2.29%
controls:0.47%
cases:14.09%
controls:8.32%
cases:48.15%
controls:40.93%
cases:71.19%
controls:66.19%
697
6578
701
7378
656
5545
742
8411
192
1251
1206
12705
32
66
1366
13890
197
1157
1201
12757
652
5502
702
7939
776
7109
314
3632
Wide-field/panoramic imaging of ocular fundus
CK2L4 [2001301452]
—
—
—
1.0e+50
—
—
3.5e+00
—
—
—
—
—
—
cases:1.14%
controls:0.00%
—
—
—
—
cases:1.74%
controls:0.06%
—
—
—
16
0
1382
13956
—
—
19
6
1071
10735
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.6e-01
3.7e-01
9.3e-01
—
9.5e-01
6.2e-01
5.8e-01
cases:14.45%
controls:11.49%
cases:8.51%
controls:6.05%
cases:2.50%
controls:1.00%
—
—
cases:2.58%
controls:1.01%
cases:10.64%
controls:6.02%
cases:25.69%
controls:16.23%
202
1604
1196
12352
119
845
1279
13111
35
140
1363
13816
—
36
141
1362
13773
144
809
1210
12632
280
1743
810
8998
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.2e+00
1.9e+00
-1.0e+50
—
—
1.5e+00
9.9e-01
cases:0.64%
controls:0.20%
cases:0.79%
controls:0.11%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.66%
controls:0.15%
cases:1.19%
controls:0.45%
9
28
1389
13928
11
16
1387
13940
0
6
1398
13950
—
—
9
20
1345
13421
13
48
1077
10693
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
8.8e-02
2.7e-01
6.3e-01
1.6e+00
6.9e-01
2.6e-01
1.9e-01
cases:31.83%
controls:29.94%
cases:30.54%
controls:25.20%
cases:9.59%
controls:5.34%
cases:1.50%
controls:0.32%
cases:9.23%
controls:4.87%
cases:31.61%
controls:26.24%
cases:52.48%
controls:47.67%
445
4179
953
9777
427
3517
971
10439
134
745
1264
13211
21
44
1377
13912
129
677
1269
13237
428
3527
926
9914
572
5120
518
5621
CD3 cells [#/volume] in Blood
8122-4 [3011412]
5.8e-01
8.7e-01
—
—
—
1.9e+00
1.5e+00
cases:0.36%
controls:0.20%
cases:0.36%
controls:0.15%
—
—
—
—
—
—
cases:0.59%
controls:0.09%
cases:1.10%
controls:0.25%
5
28
1393
13928
5
21
1393
13935
—
—
—
8
12
1346
13429
12
27
1078
10714
insulin (human); parenteral
A10AD01 [21600729]
8.0e-01
8.5e-01
5.8e-01
—
6.9e-01
9.2e-01
7.9e-01
cases:2.50%
controls:1.14%
cases:1.79%
controls:0.77%
cases:0.36%
controls:0.20%
—
—
cases:0.36%
controls:0.18%
cases:1.85%
controls:0.74%
cases:2.20%
controls:1.01%
35
159
1363
13797
25
108
1373
13848
5
28
1393
13928
—
5
25
1393
13889
25
100
1329
13341
24
109
1066
10632
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
7.1e-01
1.2e+00
—
—
—
2.1e+00
8.9e-01
cases:1.22%
controls:0.60%
cases:0.86%
controls:0.26%
—
—
—
—
—
—
cases:1.26%
controls:0.15%
cases:1.47%
controls:0.61%
17
84
1381
13872
12
36
1386
13920
—
—
—
17
20
1337
13421
16
65
1074
10676
General Practice
1 [38004446]
2.3e-01
3.0e-01
6.9e-01
3.1e+00
4.9e-01
2.2e-01
2.9e-01
cases:18.45%
controls:15.27%
cases:8.08%
controls:6.09%
cases:1.86%
controls:0.94%
cases:1.50%
controls:0.07%
cases:1.36%
controls:0.84%
cases:8.20%
controls:6.70%
cases:22.66%
controls:18.05%
258
2131
1140
11825
113
850
1285
13106
26
131
1372
13825
21
10
1377
13946
19
117
1379
13797
111
900
1243
12541
247
1939
843
8802
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
3.0e-01
9.9e-02
8.2e-02
3.3e+00
5.0e-01
3.1e-01
2.5e-01
cases:8.37%
controls:6.35%
cases:3.86%
controls:3.51%
cases:0.72%
controls:0.66%
cases:1.00%
controls:0.04%
cases:1.14%
controls:0.70%
cases:5.10%
controls:3.80%
cases:11.10%
controls:8.90%
117
886
1281
13070
54
490
1344
13466
10
92
1388
13864
14
5
1384
13951
16
97
1382
13817
69
511
1285
12930
121
956
969
9785
Oral Surgery
19 [38004464]
1.1e+00
1.4e+00
—
—
—
6.1e-01
8.5e-01
cases:1.65%
controls:0.57%
cases:0.93%
controls:0.23%
—
—
—
—
—
—
cases:0.52%
controls:0.28%
cases:1.83%
controls:0.79%
23
79
1375
13877
13
32
1385
13924
—
—
—
7
38
1347
13403
20
85
1070
10656
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
5.6e-01
5.4e-01
9.4e-01
—
1.6e+00
6.5e-01
4.7e-01
cases:5.15%
controls:3.01%
cases:3.08%
controls:1.81%
cases:0.79%
controls:0.31%
—
—
cases:0.86%
controls:0.17%
cases:3.55%
controls:1.89%
cases:8.81%
controls:5.68%
72
420
1326
13536
43
253
1355
13703
11
43
1387
13913
—
12
24
1386
13890
48
254
1306
13187
96
610
994
10131
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.2e+00
1.1e+00
—
—
—
8.4e-01
9.4e-01
cases:1.86%
controls:0.57%
cases:1.00%
controls:0.32%
—
—
—
—
—
—
cases:1.11%
controls:0.48%
cases:2.39%
controls:0.95%
26
79
1372
13877
14
45
1384
13911
—
—
—
15
65
1339
13376
26
102
1064
10639
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.4e-01
5.0e-01
7.3e-01
—
7.9e-01
4.6e-01
4.5e-01
cases:17.17%
controls:12.86%
cases:10.94%
controls:6.94%
cases:3.00%
controls:1.48%
—
—
cases:3.08%
controls:1.42%
cases:10.34%
controls:6.76%
cases:26.51%
controls:18.77%
240
1795
1158
12161
153
969
1245
12987
42
206
1356
13750
—
43
198
1355
13716
140
909
1214
12532
289
2016
801
8725
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.1e-01
2.9e-01
4.8e-01
1.6e+00
5.9e-01
3.0e-01
2.3e-01
cases:50.00%
controls:47.27%
cases:46.92%
controls:39.78%
cases:13.81%
controls:8.99%
cases:2.29%
controls:0.47%
cases:14.16%
controls:8.36%
cases:48.23%
controls:40.92%
cases:71.19%
controls:66.22%
699
6597
699
7359
656
5552
742
8404
193
1254
1205
12702
32
66
1366
13890
198
1163
1200
12751
653
5500
701
7941
776
7113
314
3628
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.1e-01
2.9e-01
4.9e-01
1.6e+00
5.9e-01
2.9e-01
2.3e-01
cases:49.93%
controls:47.26%
cases:46.85%
controls:39.80%
cases:13.88%
controls:8.99%
cases:2.29%
controls:0.47%
cases:14.16%
controls:8.36%
cases:48.15%
controls:40.95%
cases:71.10%
controls:66.26%
698
6595
700
7361
655
5555
743
8401
194
1255
1204
12701
32
66
1366
13890
198
1163
1200
12751
652
5504
702
7937
775
7117
315
3624
methylprednisolone; oral, parenteral
H02AB04 [21602732]
5.5e-01
1.1e+00
—
—
1.0e+00
1.2e+00
1.0e+00
cases:2.93%
controls:1.72%
cases:1.72%
controls:0.59%
—
—
—
—
cases:0.36%
controls:0.13%
cases:1.99%
controls:0.63%
cases:3.39%
controls:1.25%
41
240
1357
13716
24
83
1374
13873
—
—
5
18
1393
13896
27
85
1327
13356
37
134
1053
10607
MCH [Entitic mass]
28539-5 [3035941]
1.1e-01
2.9e-01
4.9e-01
1.6e+00
5.9e-01
2.9e-01
2.2e-01
cases:49.86%
controls:47.23%
cases:46.85%
controls:39.77%
cases:13.81%
controls:8.97%
cases:2.29%
controls:0.47%
cases:14.16%
controls:8.35%
cases:48.08%
controls:40.92%
cases:71.01%
controls:66.23%
697
6591
701
7365
655
5550
743
8406
193
1252
1205
12704
32
66
1366
13890
198
1162
1200
12752
651
5500
703
7941
774
7114
316
3627
Thorax X-ray examination
GD1AA [2001303617]
4.0e-01
6.5e-01
7.4e-01
—
1.1e+00
4.8e-01
6.2e-01
cases:15.02%
controls:10.62%
cases:7.73%
controls:4.18%
cases:1.29%
controls:0.62%
—
—
cases:1.36%
controls:0.45%
cases:5.83%
controls:3.70%
cases:18.53%
controls:10.92%
210
1482
1188
12474
108
584
1290
13372
18
86
1380
13870
—
19
63
1379
13851
79
497
1275
12944
202
1173
888
9568
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.1e-01
2.9e-01
4.8e-01
1.6e+00
5.9e-01
2.9e-01
2.3e-01
cases:50.07%
controls:47.32%
cases:47.00%
controls:39.88%
cases:13.81%
controls:9.01%
cases:2.29%
controls:0.47%
cases:14.16%
controls:8.37%
cases:48.30%
controls:41.07%
cases:71.28%
controls:66.32%
700
6604
698
7352
657
5566
741
8390
193
1257
1205
12699
32
66
1366
13890
198
1165
1200
12749
654
5520
700
7921
777
7123
313
3618
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.1e-01
2.9e-01
4.8e-01
1.6e+00
5.9e-01
2.9e-01
2.3e-01
cases:50.00%
controls:47.26%
cases:46.92%
controls:39.83%
cases:13.81%
controls:9.01%
cases:2.29%
controls:0.47%
cases:14.16%
controls:8.36%
cases:48.15%
controls:40.97%
cases:71.10%
controls:66.25%
699
6595
699
7361
656
5558
742
8398
193
1257
1205
12699
32
66
1366
13890
198
1163
1200
12751
652
5507
702
7934
775
7116
315
3625
Base excess in Arterial blood by calculation
1925-7 [3003396]
5.6e-01
4.1e-01
1.3e+00
—
1.9e+00
7.9e-01
3.1e-01
cases:3.79%
controls:2.21%
cases:1.36%
controls:0.91%
cases:0.36%
controls:0.09%
—
—
cases:0.57%
controls:0.09%
cases:1.92%
controls:0.88%
cases:5.14%
controls:3.81%
53
308
1345
13648
19
127
1379
13829
5
13
1393
13943
—
8
12
1390
13902
26
118
1328
13323
56
409
1034
10332
pH of Arterial blood
2744-1 [3019977]
5.5e-01
4.1e-01
1.5e+00
—
1.8e+00
8.8e-01
3.3e-01
cases:3.79%
controls:2.22%
cases:1.36%
controls:0.91%
cases:0.36%
controls:0.08%
—
—
cases:0.57%
controls:0.09%
cases:2.07%
controls:0.87%
cases:5.23%
controls:3.80%
53
310
1345
13646
19
127
1379
13829
5
11
1393
13945
—
8
13
1390
13901
28
117
1326
13324
57
408
1033
10333
Lumbar puncture
TAB00 [2001300538]
6.7e-01
1.1e+00
—
—
—
1.8e+00
1.5e+00
cases:0.93%
controls:0.48%
cases:0.43%
controls:0.14%
—
—
—
—
—
—
cases:0.74%
controls:0.13%
cases:1.28%
controls:0.30%
13
67
1385
13889
6
20
1392
13936
—
—
—
10
17
1344
13424
14
32
1076
10709
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.1e-01
2.9e-01
4.9e-01
1.6e+00
5.9e-01
2.9e-01
2.2e-01
cases:50.00%
controls:47.31%
cases:46.92%
controls:39.87%
cases:13.88%
controls:9.02%
cases:2.29%
controls:0.48%
cases:14.16%
controls:8.37%
cases:48.23%
controls:40.99%
cases:71.10%
controls:66.33%
699
6602
699
7354
656
5564
742
8392
194
1259
1204
12697
32
67
1366
13889
198
1164
1200
12750
653
5510
701
7931
775
7124
315
3617
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.5e-01
3.9e-01
8.9e-01
—
8.8e-01
5.6e-01
5.2e-01
cases:16.02%
controls:12.91%
cases:9.94%
controls:6.99%
cases:2.93%
controls:1.23%
—
—
cases:2.72%
controls:1.15%
cases:11.96%
controls:7.21%
cases:28.53%
controls:19.16%
224
1802
1174
12154
139
975
1259
12981
41
171
1357
13785
—
38
160
1360
13754
162
969
1192
12472
311
2058
779
8683
CBC panel - Blood by Automated count
58410-2 [40761511]
1.5e-01
2.7e-01
4.3e-01
1.8e+00
5.7e-01
2.1e-01
1.9e-01
cases:43.20%
controls:39.48%
cases:32.55%
controls:26.98%
cases:7.51%
controls:5.02%
cases:1.36%
controls:0.24%
cases:8.30%
controls:4.89%
cases:31.17%
controls:26.87%
cases:57.43%
controls:52.62%
604
5510
794
8446
455
3765
943
10191
105
700
1293
13256
19
33
1379
13923
116
680
1282
13234
422
3611
932
9830
626
5652
464
5089
Sleep apnoea
G47.3 [45562094]
-1.2e-01
1.3e-02
2.4e-01
3.2e+00
8.0e-01
1.6e-01
2.3e-01
cases:4.79%
controls:5.39%
cases:3.51%
controls:3.46%
cases:0.93%
controls:0.73%
cases:0.86%
controls:0.04%
cases:1.36%
controls:0.62%
cases:4.14%
controls:3.54%
cases:8.44%
controls:6.80%
67
752
1331
13204
49
483
1349
13473
13
102
1385
13854
12
5
1386
13951
19
86
1379
13828
56
476
1298
12965
92
730
998
10011
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
5.4e-01
3.4e-01
1.6e+00
—
1.8e+00
8.1e-01
3.2e-01
cases:3.72%
controls:2.20%
cases:1.29%
controls:0.92%
cases:0.36%
controls:0.07%
—
—
cases:0.57%
controls:0.09%
cases:1.99%
controls:0.90%
cases:5.23%
controls:3.85%
52
307
1346
13649
18
128
1380
13828
5
10
1393
13946
—
8
13
1390
13901
27
121
1327
13320
57
413
1033
10328
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
5.4e-01
3.4e-01
1.6e+00
—
1.8e+00
8.1e-01
3.2e-01
cases:3.72%
controls:2.21%
cases:1.29%
controls:0.92%
cases:0.36%
controls:0.07%
—
—
cases:0.57%
controls:0.09%
cases:1.99%
controls:0.90%
cases:5.23%
controls:3.84%
52
308
1346
13648
18
128
1380
13828
5
10
1393
13946
—
8
13
1390
13901
27
121
1327
13320
57
412
1033
10329
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
8.8e-01
1.4e+00
—
—
—
1.2e+00
8.8e-01
cases:2.58%
controls:1.08%
cases:1.57%
controls:0.39%
—
—
—
—
—
—
cases:0.74%
controls:0.22%
cases:2.02%
controls:0.85%
36
151
1362
13805
22
55
1376
13901
—
—
—
10
30
1344
13411
22
91
1068
10650
Laboratory Visit
OMOP4822461 [32036]
7.2e-02
2.3e-01
4.3e-01
1.6e+00
5.9e-01
2.9e-01
1.8e-01
cases:53.51%
controls:51.71%
cases:54.51%
controls:48.67%
cases:22.10%
controls:15.56%
cases:3.86%
controls:0.80%
cases:23.61%
controls:14.68%
cases:58.20%
controls:51.00%
cases:74.04%
controls:70.46%
748
7217
650
6739
762
6792
636
7164
309
2171
1089
11785
54
112
1344
13844
330
2042
1068
11872
788
6855
566
6586
807
7568
283
3173
Emergency Room and Inpatient Visit
ERIP [262]
4.2e-01
4.0e-01
1.2e+00
—
1.2e+00
2.8e-01
3.6e-01
cases:8.01%
controls:5.42%
cases:4.79%
controls:3.27%
cases:1.79%
controls:0.54%
—
—
cases:1.43%
controls:0.45%
cases:5.10%
controls:3.89%
cases:17.25%
controls:12.69%
112
757
1286
13199
67
457
1331
13499
25
76
1373
13880
—
20
63
1378
13851
69
523
1285
12918
188
1363
902
9378
Atherosclerosis of arteries of extremities
I70.2 [45538421]
6.4e-01
5.1e-01
—
—
1.5e+00
9.2e-01
3.2e-01
cases:2.86%
controls:1.53%
cases:1.43%
controls:0.86%
—
—
—
—
cases:0.93%
controls:0.20%
cases:2.36%
controls:0.95%
cases:2.94%
controls:2.14%
40
214
1358
13742
20
120
1378
13836
—
—
13
28
1385
13886
32
128
1322
13313
32
230
1058
10511
Asthma, unspecified
J45.9 [45562456]
2.7e-01
2.1e-01
7.7e-01
3.1e+00
5.5e-01
3.3e-01
1.6e-01
cases:4.65%
controls:3.58%
cases:2.22%
controls:1.81%
cases:0.79%
controls:0.37%
cases:0.79%
controls:0.04%
cases:0.64%
controls:0.37%
cases:2.81%
controls:2.04%
cases:5.69%
controls:4.88%
65
500
1333
13456
31
252
1367
13704
11
51
1387
13905
11
5
1387
13951
9
52
1389
13862
38
274
1316
13167
62
524
1028
10217
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
4.7e-01
7.1e-01
1.0e+00
—
8.4e-01
4.8e-01
4.1e-01
cases:11.30%
controls:7.35%
cases:5.94%
controls:3.02%
cases:1.29%
controls:0.47%
—
—
cases:1.07%
controls:0.47%
cases:5.10%
controls:3.22%
cases:11.38%
controls:7.82%
158
1026
1240
12930
83
422
1315
13534
18
65
1380
13891
—
15
65
1383
13849
69
433
1285
13008
124
840
966
9901
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9654-5 [3007847]
1.7e+00
—
—
—
—
1.5e+00
1.4e+00
cases:0.64%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.10%
cases:0.92%
controls:0.22%
9
17
1389
13939
—
—
—
—
6
13
1348
13428
10
24
1080
10717
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.5e-01
3.1e-01
4.8e-01
1.2e+00
4.6e-01
3.3e-01
2.5e-01
cases:45.06%
controls:41.49%
cases:38.41%
controls:31.45%
cases:9.01%
controls:5.76%
cases:0.86%
controls:0.25%
cases:8.30%
controls:5.41%
cases:40.32%
controls:32.74%
cases:65.69%
controls:59.76%
630
5791
768
8165
537
4389
861
9567
126
804
1272
13152
12
35
1386
13921
116
753
1282
13161
546
4401
808
9040
716
6419
374
4322
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.3e-01
4.4e-01
6.4e-01
1.6e+00
6.7e-01
4.4e-01
4.5e-01
cases:14.81%
controls:10.17%
cases:12.30%
controls:8.28%
cases:3.51%
controls:1.88%
cases:0.43%
controls:0.09%
cases:3.36%
controls:1.75%
cases:13.07%
controls:8.82%
cases:24.86%
controls:17.41%
207
1419
1191
12537
172
1156
1226
12800
49
263
1349
13693
6
12
1392
13944
47
244
1351
13670
177
1186
1177
12255
271
1870
819
8871
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
9.1e-01
1.5e+00
—
—
1.0e+50
1.5e+00
4.9e-01
cases:1.14%
controls:0.47%
cases:0.79%
controls:0.17%
—
—
—
—
cases:0.64%
controls:0.00%
cases:0.96%
controls:0.21%
cases:1.10%
controls:0.68%
16
65
1382
13891
11
24
1387
13932
—
—
9
0
1389
13914
13
28
1341
13413
12
73
1078
10668
Bacteria [Presence] in Urine
87829-8 [36304419]
3.4e-01
5.0e-01
5.8e-01
—
1.1e+00
6.1e-01
5.1e-01
cases:8.87%
controls:6.51%
cases:5.29%
controls:3.29%
cases:0.93%
controls:0.52%
—
—
cases:1.07%
controls:0.36%
cases:5.76%
controls:3.21%
cases:14.04%
controls:8.95%
124
908
1274
13048
74
459
1324
13497
13
73
1385
13883
—
15
50
1383
13864
78
432
1276
13009
153
961
937
9780
Neck artery ultrasound examination with Doppler method
PA6DE [2001308705]
1.1e+00
1.1e+00
—
1.0e+50
—
2.0e+00
7.7e-01
cases:1.50%
controls:0.53%
cases:0.43%
controls:0.15%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.59%
controls:0.08%
cases:0.64%
controls:0.30%
21
74
1377
13882
6
21
1392
13935
—
5
0
1393
13956
—
8
11
1346
13430
7
32
1083
10709
insulin glargine; parenteral
A10AE04 [21600739]
8.5e-01
7.1e-01
8.7e-01
—
6.7e-01
6.0e-01
4.6e-01
cases:5.44%
controls:2.41%
cases:4.65%
controls:2.35%
cases:1.36%
controls:0.57%
—
—
cases:1.50%
controls:0.78%
cases:4.51%
controls:2.52%
cases:5.50%
controls:3.55%
76
336
1322
13620
65
328
1333
13628
19
80
1379
13876
—
21
108
1377
13806
61
339
1293
13102
60
381
1030
10360
insulin (beef); parenteral
A10AD02 [21600730]
8.5e-01
7.1e-01
8.7e-01
—
6.7e-01
6.0e-01
4.6e-01
cases:5.44%
controls:2.41%
cases:4.65%
controls:2.35%
cases:1.36%
controls:0.57%
—
—
cases:1.50%
controls:0.78%
cases:4.51%
controls:2.52%
cases:5.50%
controls:3.55%
76
336
1322
13620
65
328
1333
13628
19
80
1379
13876
—
21
108
1377
13806
61
339
1293
13102
60
381
1030
10360
Standard cardiac ultrasound examination
FM1AE [2001303278]
5.8e-01
7.4e-01
1.0e+00
—
1.5e+00
8.6e-01
8.4e-01
cases:5.79%
controls:3.33%
cases:2.72%
controls:1.32%
cases:0.36%
controls:0.13%
—
—
cases:0.50%
controls:0.11%
cases:2.51%
controls:1.08%
cases:7.25%
controls:3.25%
81
465
1317
13491
38
184
1360
13772
5
18
1393
13938
—
7
15
1391
13899
34
145
1320
13296
79
349
1011
10392
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
4.2e-01
8.3e-01
2.2e+00
—
—
6.5e-01
4.5e-01
cases:3.29%
controls:2.18%
cases:1.65%
controls:0.72%
cases:0.43%
controls:0.05%
—
—
—
—
cases:1.26%
controls:0.66%
cases:3.76%
controls:2.44%
46
304
1352
13652
23
101
1375
13855
6
7
1392
13949
—
—
17
89
1337
13352
41
262
1049
10479
Sprain and strain of cervical spine
S13.4 [45573197]
1.3e+00
-1.0e+50
—
—
—
1.7e+00
3.4e-01
cases:0.79%
controls:0.21%
cases:0.00%
controls:0.04%
—
—
—
—
—
—
cases:0.59%
controls:0.11%
cases:0.46%
controls:0.33%
11
30
1387
13926
0
5
1398
13951
—
—
—
8
15
1346
13426
5
35
1085
10706
More than one and less than three hours
ZXE10 [2001311401]
4.0e-01
7.3e-01
—
—
1.5e+00
9.8e-01
8.6e-01
cases:9.08%
controls:6.26%
cases:3.15%
controls:1.54%
—
—
—
—
cases:0.57%
controls:0.13%
cases:2.36%
controls:0.90%
cases:7.71%
controls:3.42%
127
874
1271
13082
44
215
1354
13741
—
—
8
18
1390
13896
32
121
1322
13320
84
367
1006
10374
Protein C actual/normal in Platelet poor plasma by Coagulation assay
27819-2 [3020287]
5.3e-01
1.7e+00
—
—
—
1.5e+00
1.3e+00
cases:0.57%
controls:0.34%
cases:0.57%
controls:0.11%
—
—
—
—
—
—
cases:0.37%
controls:0.08%
cases:1.01%
controls:0.28%
8
47
1390
13909
8
15
1390
13941
—
—
—
5
11
1349
13430
11
30
1079
10711
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
4.9e-01
9.8e-01
—
—
1.5e+00
1.1e+00
8.2e-01
cases:2.79%
controls:1.72%
cases:2.07%
controls:0.79%
—
—
—
—
cases:0.50%
controls:0.11%
cases:2.29%
controls:0.75%
cases:4.31%
controls:1.95%
39
240
1359
13716
29
110
1369
13846
—
—
7
15
1391
13899
31
101
1323
13340
47
209
1043
10532
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
9.6e-01
9.0e-01
-1.0e+50
—
—
1.0e+00
9.4e-01
cases:2.00%
controls:0.77%
cases:0.86%
controls:0.35%
cases:0.00%
controls:0.05%
—
—
—
—
cases:1.11%
controls:0.40%
cases:3.03%
controls:1.21%
28
108
1370
13848
12
49
1386
13907
0
7
1398
13949
—
—
15
54
1339
13387
33
130
1057
10611
Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]
9.2e-01
1.5e+00
—
—
—
1.7e+00
1.3e+00
cases:0.79%
controls:0.32%
cases:0.50%
controls:0.11%
—
—
—
—
—
—
cases:0.74%
controls:0.14%
cases:1.19%
controls:0.34%
11
44
1387
13912
7
15
1391
13941
—
—
—
10
19
1344
13422
13
37
1077
10704
adalimumab; parenteral
L04AB04 [21603911]
1.4e+00
1.5e+00
—
—
1.7e+00
1.3e+00
8.6e-01
cases:0.79%
controls:0.20%
cases:0.79%
controls:0.17%
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.59%
controls:0.16%
cases:0.55%
controls:0.23%
11
28
1387
13928
11
24
1387
13932
—
—
5
9
1393
13905
8
21
1346
13420
6
25
1084
10716
methotrexate; oral, parenteral
L04AX03 [21603929]
6.1e-01
7.0e-01
6.5e-01
—
7.5e-01
7.5e-01
8.4e-01
cases:3.93%
controls:2.17%
cases:3.36%
controls:1.70%
cases:1.14%
controls:0.60%
—
—
cases:1.36%
controls:0.65%
cases:3.62%
controls:1.75%
cases:5.23%
controls:2.34%
55
303
1343
13653
47
237
1351
13719
16
84
1382
13872
—
19
90
1379
13824
49
235
1305
13206
57
251
1033
10490
methotrexate
L01BA01 [21601423]
6.1e-01
7.0e-01
6.5e-01
—
7.5e-01
7.5e-01
8.4e-01
cases:3.93%
controls:2.17%
cases:3.36%
controls:1.70%
cases:1.14%
controls:0.60%
—
—
cases:1.36%
controls:0.65%
cases:3.62%
controls:1.75%
cases:5.23%
controls:2.34%
55
303
1343
13653
47
237
1351
13719
16
84
1382
13872
—
19
90
1379
13824
49
235
1305
13206
57
251
1033
10490
Glaucoma
114 [2001600114]
1.1e+00
1.8e+00
—
—
—
1.3e+00
7.4e-01
cases:2.15%
controls:0.75%
cases:1.00%
controls:0.17%
—
—
—
—
—
—
cases:0.74%
controls:0.20%
cases:1.47%
controls:0.71%
30
105
1368
13851
14
24
1384
13932
—
—
—
10
27
1344
13414
16
76
1074
10665
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.7e-01
4.2e-01
6.6e-01
1.5e+00
6.0e-01
4.8e-01
4.0e-01
cases:29.26%
controls:24.03%
cases:20.46%
controls:14.45%
cases:5.29%
controls:2.82%
cases:0.50%
controls:0.11%
cases:4.65%
controls:2.61%
cases:21.20%
controls:14.32%
cases:42.84%
controls:33.40%
409
3353
989
10603
286
2017
1112
11939
74
393
1324
13563
7
16
1391
13940
65
363
1333
13551
287
1925
1067
11516
467
3587
623
7154
Short blood count panel - Blood
55429-5 [40758558]
6.3e-01
8.4e-01
6.8e-01
—
7.7e-01
7.5e-01
5.8e-01
cases:11.44%
controls:6.41%
cases:7.15%
controls:3.21%
cases:1.57%
controls:0.80%
—
—
cases:1.43%
controls:0.67%
cases:6.72%
controls:3.28%
cases:14.13%
controls:8.42%
160
895
1238
13061
100
448
1298
13508
22
112
1376
13844
—
20
93
1378
13821
91
441
1263
13000
154
904
936
9837
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.5e-01
4.2e-01
4.7e-01
—
1.1e+00
5.6e-01
4.0e-01
cases:12.45%
controls:9.11%
cases:6.80%
controls:4.55%
cases:1.22%
controls:0.77%
—
—
cases:1.50%
controls:0.52%
cases:7.46%
controls:4.41%
cases:17.61%
controls:12.50%
174
1272
1224
12684
95
635
1303
13321
17
107
1381
13849
—
21
72
1377
13842
101
593
1253
12848
192
1343
898
9398
Upper gastrointestinal surgery
106 [44777669]
2.9e-01
4.7e-01
9.6e-01
—
8.1e-01
6.4e-01
4.3e-01
cases:13.95%
controls:10.83%
cases:6.58%
controls:4.21%
cases:1.86%
controls:0.72%
—
—
cases:1.29%
controls:0.57%
cases:6.94%
controls:3.79%
cases:16.88%
controls:11.63%
195
1512
1203
12444
92
588
1306
13368
26
101
1372
13855
—
18
80
1380
13834
94
510
1260
12931
184
1249
906
9492
Physical Medicine And Rehabilitation
25 [38004468]
3.7e-01
3.5e-01
4.0e-01
—
1.2e+00
6.7e-01
5.4e-01
cases:10.09%
controls:7.21%
cases:3.79%
controls:2.69%
cases:0.79%
controls:0.53%
—
—
cases:1.14%
controls:0.35%
cases:4.51%
controls:2.35%
cases:11.10%
controls:6.79%
141
1006
1257
12950
53
376
1345
13580
11
74
1387
13882
—
16
49
1382
13865
61
316
1293
13125
121
729
969
10012
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
4.7e-01
5.3e-01
1.2e+00
—
1.2e+00
3.3e-01
5.0e-01
cases:7.15%
controls:4.59%
cases:3.72%
controls:2.21%
cases:1.00%
controls:0.29%
—
—
cases:0.86%
controls:0.27%
cases:3.32%
controls:2.41%
cases:11.19%
controls:7.10%
100
640
1298
13316
52
309
1346
13647
14
41
1384
13915
—
12
37
1386
13877
45
324
1309
13117
122
763
968
9978
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.1e-01
4.7e-01
5.4e-01
—
9.9e-01
5.3e-01
3.4e-01
cases:9.73%
controls:6.65%
cases:5.51%
controls:3.50%
cases:1.00%
controls:0.59%
—
—
cases:1.07%
controls:0.40%
cases:5.69%
controls:3.44%
cases:13.03%
controls:9.66%
136
928
1262
13028
77
489
1321
13467
14
82
1384
13874
—
15
56
1383
13858
77
462
1277
12979
142
1038
948
9703
Gas panel - Venous blood
24339-4 [3000991]
7.2e-01
8.4e-01
1.6e+00
—
1.5e+00
1.2e+00
4.9e-01
cases:2.86%
controls:1.42%
cases:1.86%
controls:0.81%
cases:0.43%
controls:0.09%
—
—
cases:0.57%
controls:0.12%
cases:2.14%
controls:0.67%
cases:4.40%
controls:2.74%
40
198
1358
13758
26
113
1372
13843
6
12
1392
13944
—
8
17
1390
13897
29
90
1325
13351
48
294
1042
10447
bromfenac
S01BC11 [21603649]
—
2.7e+00
—
—
—
1.9e+00
7.9e-01
—
—
cases:0.64%
controls:0.04%
—
—
—
—
—
—
cases:0.44%
controls:0.07%
cases:1.10%
controls:0.50%
—
9
6
1389
13950
—
—
—
6
9
1348
13432
12
54
1078
10687
Transplant complication
127 [2001600125]
2.7e+00
—
—
—
—
—
—
cases:0.64%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
9
6
1389
13950
—
—
—
—
—
—
Myopia
H52.1 [45533352]
—
1.3e+00
—
1.0e+50
—
2.7e+00
1.4e+00
—
—
cases:0.36%
controls:0.09%
—
—
cases:0.64%
controls:0.00%
—
—
cases:0.89%
controls:0.06%
cases:0.83%
controls:0.20%
—
5
13
1393
13943
—
9
0
1389
13956
—
12
8
1342
13433
9
22
1081
10719
Gastroenterology
10 [38004455]
5.8e-01
3.5e-01
9.5e-01
—
4.0e-01
7.5e-01
3.9e-01
cases:10.16%
controls:5.93%
cases:3.58%
controls:2.56%
cases:1.14%
controls:0.44%
—
—
cases:0.72%
controls:0.48%
cases:4.95%
controls:2.41%
cases:10.09%
controls:7.08%
142
828
1256
13128
50
357
1348
13599
16
62
1382
13894
—
10
67
1388
13847
67
324
1287
13117
110
760
980
9981
Otolaryngology
4 [38004449]
3.8e-01
3.8e-01
9.7e-01
—
9.1e-01
2.7e-01
4.0e-01
cases:16.52%
controls:11.91%
cases:6.44%
controls:4.49%
cases:2.07%
controls:0.80%
—
—
cases:1.79%
controls:0.73%
cases:5.91%
controls:4.57%
cases:17.71%
controls:12.61%
231
1662
1167
12294
90
627
1308
13329
29
111
1369
13845
—
25
101
1373
13813
80
614
1274
12827
193
1354
897
9387
Other minor procedure in eye surgery
TCW99 [2001301502]
2.6e+00
—
—
1.0e+50
—
—
2.1e+00
cases:0.79%
controls:0.06%
—
—
—
—
cases:0.57%
controls:0.00%
—
—
—
—
cases:0.46%
controls:0.06%
11
8
1387
13948
—
—
8
0
1390
13956
—
—
5
6
1085
10735
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 [3014959]
1.2e+00
—
—
—
—
2.6e+00
1.2e+00
cases:0.43%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.59%
controls:0.04%
cases:0.64%
controls:0.19%
6
18
1392
13938
—
—
—
—
8
6
1346
13435
7
20
1083
10721
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
3.0e-01
9.2e-01
9.5e-01
—
8.3e-01
1.0e+00
6.3e-01
cases:4.51%
controls:3.39%
cases:3.00%
controls:1.23%
cases:0.50%
controls:0.19%
—
—
cases:0.43%
controls:0.19%
cases:3.47%
controls:1.26%
cases:8.07%
controls:4.49%
63
473
1335
13483
42
171
1356
13785
7
27
1391
13929
—
6
26
1392
13888
47
170
1307
13271
88
482
1002
10259
Other local administration
ZX198 [2001311508]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.07%
—
—
—
—
—
—
10
8
1080
10733
Base excess in Venous blood by calculation
1927-3 [3002032]
6.4e-01
9.4e-01
1.3e+00
—
1.4e+00
9.1e-01
3.2e-01
cases:3.15%
controls:1.68%
cases:2.15%
controls:0.85%
cases:0.50%
controls:0.14%
—
—
cases:0.50%
controls:0.13%
cases:2.29%
controls:0.94%
cases:5.50%
controls:4.08%
44
234
1354
13722
30
119
1368
13837
7
19
1391
13937
—
7
18
1391
13896
31
126
1323
13315
60
438
1030
10303
Unspecified visual loss
H54.7 [45586517]
2.5e+00
—
—
—
—
—
—
cases:0.43%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
1392
13951
—
—
—
—
—
—
Other rehabilitation service
R5599 [2001310270]
1.0e+00
—
—
—
—
2.5e+00
—
cases:0.72%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.04%
—
—
10
36
1388
13920
—
—
—
—
6
5
1348
13436
—
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
3.2e-01
6.2e-01
1.1e+00
—
1.0e+00
4.6e-01
4.6e-01
cases:9.51%
controls:7.07%
cases:5.22%
controls:2.87%
cases:1.14%
controls:0.39%
—
—
cases:0.93%
controls:0.34%
cases:4.43%
controls:2.86%
cases:15.14%
controls:10.13%
133
987
1265
12969
73
401
1325
13555
16
55
1382
13901
—
13
48
1385
13866
60
384
1294
13057
165
1088
925
9653
ECG with 12 standard connections
XF400 [2001303368]
3.9e-01
8.7e-01
1.8e+00
—
-1.0e+50
9.0e-01
7.0e-01
cases:2.93%
controls:2.01%
cases:1.43%
controls:0.60%
cases:0.36%
controls:0.06%
—
—
cases:0.00%
controls:0.08%
cases:1.33%
controls:0.54%
cases:3.03%
controls:1.53%
41
280
1357
13676
20
84
1378
13872
5
8
1393
13948
—
0
11
1398
13903
18
73
1336
13368
33
164
1057
10577
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 [3030558]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.05%
—
—
—
—
—
—
6
5
1084
10736
Hematology
82 [38004501]
5.6e-01
7.8e-01
1.0e+00
—
9.9e-01
8.3e-01
8.7e-01
cases:2.22%
controls:1.28%
cases:1.93%
controls:0.90%
cases:0.79%
controls:0.28%
—
—
cases:1.00%
controls:0.37%
cases:2.07%
controls:0.92%
cases:3.67%
controls:1.57%
31
179
1367
13777
27
125
1371
13831
11
39
1387
13917
—
14
52
1384
13862
28
123
1326
13318
40
169
1050
10572
valaciclovir; oral
J05AB11 [21603137]
3.0e-01
6.7e-01
—
—
1.6e+00
9.1e-01
4.9e-01
cases:3.00%
controls:2.24%
cases:1.79%
controls:0.92%
—
—
—
—
cases:0.79%
controls:0.17%
cases:2.22%
controls:0.91%
cases:4.13%
controls:2.58%
42
313
1356
13643
25
129
1373
13827
—
—
11
23
1387
13891
30
122
1324
13319
45
277
1045
10464
azathioprine; oral, parenteral
L04AX01 [21603927]
8.0e-01
6.2e-01
—
—
8.2e-01
1.2e+00
1.2e+00
cases:1.29%
controls:0.58%
cases:0.72%
controls:0.39%
—
—
—
—
cases:0.36%
controls:0.16%
cases:1.18%
controls:0.35%
cases:1.56%
controls:0.46%
18
81
1380
13875
10
54
1388
13902
—
—
5
22
1393
13892
16
47
1338
13394
17
49
1073
10692
Ultrasound examination transplanted kidney
KA2AE [2001305644]
2.5e+00
—
—
—
—
—
—
cases:0.50%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
1391
13950
—
—
—
—
—
—
Obstetrics / Gynecology
16 [38004461]
2.1e-01
3.6e-01
5.3e-01
2.5e+00
3.7e-01
1.5e-01
2.5e-01
cases:13.09%
controls:10.91%
cases:6.08%
controls:4.33%
cases:1.29%
controls:0.76%
cases:0.50%
controls:0.04%
cases:1.00%
controls:0.70%
cases:4.58%
controls:3.97%
cases:12.39%
controls:9.94%
183
1523
1215
12433
85
604
1313
13352
18
106
1380
13850
7
6
1391
13950
14
97
1384
13817
62
534
1292
12907
135
1068
955
9673
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 [3027529]
1.2e+00
—
—
—
—
2.5e+00
1.3e+00
cases:0.43%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:0.64%
controls:0.18%
6
18
1392
13938
—
—
—
—
7
6
1347
13435
7
19
1083
10722
Day surgery
ZXD20 [2001311388]
7.5e-01
1.1e+00
—
—
—
1.7e+00
3.7e-01
cases:2.00%
controls:0.96%
cases:0.72%
controls:0.24%
—
—
—
—
—
—
cases:0.81%
controls:0.15%
cases:0.92%
controls:0.63%
28
134
1370
13822
10
33
1388
13923
—
—
—
11
20
1343
13421
10
68
1080
10673
Diastolic blood pressure
8462-4 [3012888]
1.7e+00
—
—
—
—
—
2.4e+00
cases:0.43%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.06%
6
11
1392
13945
—
—
—
—
—
7
6
1083
10735
Systolic blood pressure
8480-6 [3004249]
1.7e+00
—
—
—
—
—
2.4e+00
cases:0.43%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.06%
6
11
1392
13945
—
—
—
—
—
7
6
1083
10735
hydroxychloroquine; oral
P01BA02 [21604889]
8.2e-01
9.2e-01
3.6e-01
—
9.6e-01
7.0e-01
6.2e-01
cases:3.65%
controls:1.65%
cases:3.08%
controls:1.25%
cases:0.43%
controls:0.30%
—
—
cases:0.86%
controls:0.33%
cases:2.51%
controls:1.26%
cases:3.12%
controls:1.70%
51
230
1347
13726
43
174
1355
13782
6
42
1392
13914
—
12
46
1386
13868
34
169
1320
13272
34
183
1056
10558
Anogenital (venereal) warts
A63.0 [45585929]
—
—
—
—
—
-1.0e+50
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.73%
controls:0.07%
—
—
—
—
—
0
11
1354
13430
8
7
1082
10734
pH of Venous blood
2746-6 [3012544]
6.0e-01
9.4e-01
1.4e+00
—
1.5e+00
8.3e-01
2.4e-01
cases:3.08%
controls:1.71%
cases:2.15%
controls:0.85%
cases:0.57%
controls:0.14%
—
—
cases:0.57%
controls:0.13%
cases:2.22%
controls:0.98%
cases:5.32%
controls:4.24%
43
238
1355
13718
30
119
1368
13837
8
19
1390
13937
—
8
18
1390
13896
30
132
1324
13309
58
455
1032
10286
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
1.3e+00
—
—
—
—
7.9e-01
1.0e+00
cases:1.65%
controls:0.44%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.20%
cases:1.38%
controls:0.50%
23
61
1375
13895
—
—
—
—
6
27
1348
13414
15
54
1075
10687
Office Visit
OMOP4822458 [581477]
3.3e-01
7.5e-01
8.2e-01
—
1.2e+00
6.5e-01
6.1e-01
cases:11.59%
controls:8.59%
cases:4.72%
controls:2.29%
cases:0.86%
controls:0.38%
—
—
cases:0.86%
controls:0.27%
cases:4.21%
controls:2.24%
cases:9.82%
controls:5.60%
162
1199
1236
12757
66
319
1332
13637
12
53
1386
13903
—
12
38
1386
13876
57
301
1297
13140
107
602
983
10139
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
7.0e-01
1.0e+00
-1.0e+50
—
—
1.6e+00
8.4e-01
cases:2.07%
controls:1.04%
cases:1.00%
controls:0.37%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.26%
controls:0.25%
cases:1.83%
controls:0.80%
29
145
1369
13811
14
51
1384
13905
0
8
1398
13948
—
—
17
34
1337
13407
20
86
1070
10655
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
5.8e-01
8.6e-01
1.1e+00
—
1.3e+00
8.7e-01
4.5e-01
cases:3.86%
controls:2.19%
cases:2.50%
controls:1.07%
cases:0.50%
controls:0.17%
—
—
cases:0.64%
controls:0.17%
cases:2.58%
controls:1.10%
cases:5.50%
controls:3.58%
54
306
1344
13650
35
150
1363
13806
7
24
1391
13932
—
9
24
1389
13890
35
148
1319
13293
60
384
1030
10357
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
1.0e+00
7.2e-01
—
—
—
1.3e+00
6.2e-01
cases:1.86%
controls:0.69%
cases:0.72%
controls:0.35%
—
—
—
—
—
—
cases:1.03%
controls:0.28%
cases:1.65%
controls:0.89%
26
96
1372
13860
10
49
1388
13907
—
—
—
14
38
1340
13403
18
96
1072
10645
Primary open-angle glaucoma
H40.1 [45533312]
4.5e-01
2.3e+00
—
—
—
1.7e+00
—
cases:0.57%
controls:0.37%
cases:0.79%
controls:0.08%
—
—
—
—
—
—
cases:0.44%
controls:0.08%
—
—
8
51
1390
13905
11
11
1387
13945
—
—
—
6
11
1348
13430
—
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
9.2e-01
2.3e+00
—
—
—
1.9e+00
1.2e+00
cases:0.79%
controls:0.32%
cases:0.79%
controls:0.08%
—
—
—
—
—
—
cases:0.44%
controls:0.07%
cases:0.92%
controls:0.28%
11
44
1387
13912
11
11
1387
13945
—
—
—
6
9
1348
13432
10
30
1080
10711
Ultrasound oculometry
CA1ME [2001300876]
2.3e+00
—
—
—
—
—
—
cases:0.57%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
8
8
1390
13948
—
—
—
—
—
—
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
2.4e-02
-1.9e-02
7.6e-01
2.3e+00
4.9e-01
1.7e-01
1.9e-01
cases:9.80%
controls:9.59%
cases:4.72%
controls:4.81%
cases:1.65%
controls:0.77%
cases:0.57%
controls:0.06%
cases:1.07%
controls:0.66%
cases:5.69%
controls:4.84%
cases:17.71%
controls:15.06%
137
1338
1261
12618
66
671
1332
13285
23
108
1375
13848
8
8
1390
13948
15
92
1383
13822
77
651
1277
12790
193
1618
897
9123
Vascular Surgery
77 [38004496]
6.5e-01
6.3e-01
—
—
1.3e+00
1.0e+00
2.9e-01
cases:5.87%
controls:3.16%
cases:2.50%
controls:1.35%
—
—
—
—
cases:0.50%
controls:0.14%
cases:3.18%
controls:1.16%
cases:5.05%
controls:3.84%
82
441
1316
13515
35
188
1363
13768
—
—
7
19
1391
13895
43
156
1311
13285
55
412
1035
10329
Migraine with aura [classical migraine]
G43.1 [45562086]
5.5e-01
6.5e-01
2.3e+00
—
—
6.7e-01
6.1e-01
cases:1.14%
controls:0.67%
cases:0.57%
controls:0.30%
cases:0.50%
controls:0.05%
—
—
—
—
cases:0.66%
controls:0.34%
cases:1.56%
controls:0.86%
16
93
1382
13863
8
42
1390
13914
7
7
1391
13949
—
—
9
46
1345
13395
17
92
1073
10649
HLA-A [Type]
13298-5 [3024471]
2.3e+00
—
—
—
—
—
—
cases:0.43%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
1392
13950
—
—
—
—
—
—
Simple extraction of IUD
TLC02 [2001306648]
—
2.3e+00
—
—
—
—
—
—
—
cases:0.43%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
6
6
1392
13950
—
—
—
—
—
HLA-DR beta [Type]
13306-6 [3024932]
2.3e+00
—
—
—
—
—
—
cases:0.43%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
1392
13950
—
—
—
—
—
—
Social worker
Z2446 [2001311559]
9.9e-01
1.3e+00
—
—
—
1.6e+00
1.3e+00
cases:1.72%
controls:0.64%
cases:0.64%
controls:0.17%
—
—
—
—
—
—
cases:0.44%
controls:0.09%
cases:1.19%
controls:0.33%
24
90
1374
13866
9
24
1389
13932
—
—
—
6
12
1348
13429
13
35
1077
10706
fluorometholone
S01BA07 [21603624]
8.5e-01
1.4e+00
—
—
—
1.2e+00
7.2e-01
cases:1.50%
controls:0.64%
cases:0.93%
controls:0.22%
—
—
—
—
—
—
cases:0.81%
controls:0.24%
cases:1.74%
controls:0.86%
21
90
1377
13866
13
31
1385
13925
—
—
—
11
32
1343
13409
19
92
1071
10649
Anisometropia and aniseikonia
H52.3 [45557466]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.06%
—
—
—
—
—
—
6
6
1084
10735
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
6.9e-01
9.4e-01
—
—
—
1.4e+00
9.3e-01
cases:1.65%
controls:0.83%
cases:0.79%
controls:0.31%
—
—
—
—
—
—
cases:1.03%
controls:0.27%
cases:2.48%
controls:1.00%
23
116
1375
13840
11
43
1387
13913
—
—
—
14
36
1340
13405
27
107
1063
10634
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
5.8e-01
9.0e-01
1.5e+00
—
1.4e+00
8.2e-01
5.6e-01
cases:2.43%
controls:1.38%
cases:1.86%
controls:0.77%
cases:0.43%
controls:0.10%
—
—
cases:0.50%
controls:0.13%
cases:1.85%
controls:0.82%
cases:4.68%
controls:2.73%
34
193
1364
13763
26
107
1372
13849
6
14
1392
13942
—
7
18
1391
13896
25
110
1329
13331
51
293
1039
10448
Foot/toe symptom/complaint
L17 [2002000641]
3.0e-01
4.0e-01
9.0e-01
—
1.3e+00
6.0e-01
4.2e-01
cases:7.22%
controls:5.45%
cases:3.29%
controls:2.24%
cases:0.79%
controls:0.32%
—
—
cases:0.86%
controls:0.24%
cases:3.91%
controls:2.19%
cases:10.83%
controls:7.41%
101
760
1297
13196
46
312
1352
13644
11
45
1387
13911
—
12
34
1386
13880
53
295
1301
13146
118
796
972
9945
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
4.9e-01
9.3e-01
1.0e+00
—
1.4e+00
8.4e-01
4.2e-01
cases:5.15%
controls:3.23%
cases:3.22%
controls:1.29%
cases:0.50%
controls:0.18%
—
—
cases:0.64%
controls:0.16%
cases:2.73%
controls:1.20%
cases:6.88%
controls:4.61%
72
451
1326
13505
45
180
1353
13776
7
25
1391
13931
—
9
22
1389
13892
37
161
1317
13280
75
495
1015
10246
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
4.6e-01
5.0e-01
1.2e+00
—
6.0e-01
5.7e-01
3.8e-01
cases:4.65%
controls:2.99%
cases:2.79%
controls:1.71%
cases:0.93%
controls:0.29%
—
—
cases:0.57%
controls:0.32%
cases:3.10%
controls:1.77%
cases:7.71%
controls:5.39%
65
417
1333
13539
39
238
1359
13718
13
40
1385
13916
—
8
44
1390
13870
42
238
1312
13203
84
579
1006
10162
Elevated blood pressure
K85 [2002000612]
4.2e-01
6.8e-01
1.5e+00
—
2.2e+00
8.2e-03
2.0e-01
cases:4.51%
controls:3.01%
cases:1.79%
controls:0.91%
cases:0.43%
controls:0.09%
—
—
cases:0.64%
controls:0.07%
cases:0.96%
controls:0.95%
cases:4.31%
controls:3.57%
63
420
1335
13536
25
127
1373
13829
6
13
1392
13943
—
9
10
1389
13904
13
128
1341
13313
47
383
1043
10358
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
1.8e-01
5.9e-01
—
—
2.2e+00
4.5e-01
2.4e-01
cases:4.51%
controls:3.78%
cases:2.22%
controls:1.24%
—
—
—
—
cases:0.57%
controls:0.06%
cases:1.85%
controls:1.19%
cases:5.87%
controls:4.69%
63
528
1335
13428
31
173
1367
13783
—
—
8
9
1390
13905
25
160
1329
13281
64
504
1026
10237
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
4.5e-01
1.0e+00
—
—
—
2.2e+00
1.2e+00
cases:0.79%
controls:0.50%
cases:0.36%
controls:0.13%
—
—
—
—
—
—
cases:0.59%
controls:0.07%
cases:0.92%
controls:0.28%
11
70
1387
13886
5
18
1393
13938
—
—
—
8
9
1346
13432
10
30
1080
10711
insulin lispro; parenteral
A10AD04 [21600732]
1.1e+00
1.1e+00
—
—
1.0e+00
9.0e-01
6.5e-01
cases:1.57%
controls:0.53%
cases:1.22%
controls:0.42%
—
—
—
—
cases:0.43%
controls:0.15%
cases:1.11%
controls:0.45%
cases:1.01%
controls:0.53%
22
74
1376
13882
17
58
1381
13898
—
—
6
21
1392
13893
15
61
1339
13380
11
57
1079
10684
Hereditary corneal dystrophies
H18.5 [45581612]
—
—
—
1.0e+50
—
2.2e+00
—
—
—
—
—
—
—
cases:0.43%
controls:0.00%
—
—
cases:0.52%
controls:0.06%
—
—
—
—
—
6
0
1392
13956
—
7
8
1347
13433
—
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
55774-4 [40758895]
1.5e+00
—
—
—
—
—
2.2e+00
cases:0.36%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.07%
5
11
1393
13945
—
—
—
—
—
7
8
1083
10733
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
9.9e-01
9.6e-01
1.6e+00
—
1.4e+00
1.2e+00
5.9e-01
cases:2.07%
controls:0.78%
cases:1.07%
controls:0.42%
cases:0.36%
controls:0.07%
—
—
cases:0.36%
controls:0.09%
cases:1.26%
controls:0.39%
cases:3.12%
controls:1.76%
29
109
1369
13847
15
58
1383
13898
5
10
1393
13946
—
5
12
1393
13902
17
53
1337
13388
34
189
1056
10552
Scans and measurement printouts for intraocular lens power calculation
CJ2M4 [2001301374]
2.2e+00
—
—
—
—
-1.0e+50
—
cases:0.43%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
—
—
6
7
1392
13949
—
—
—
—
0
5
1354
13436
—
Eye, Other diagnostic procedure
F43 [2002000426]
—
2.2e+00
—
—
—
—
—
—
—
cases:0.43%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
6
7
1392
13949
—
—
—
—
—
Cathetrisation of vein
TPH04 [2001309597]
6.5e-01
5.2e-01
1.6e+00
—
—
1.0e+00
4.8e-01
cases:6.29%
controls:3.38%
cases:2.07%
controls:1.25%
cases:0.57%
controls:0.12%
—
—
—
—
cases:3.03%
controls:1.12%
cases:6.42%
controls:4.06%
88
472
1310
13484
29
174
1369
13782
8
17
1390
13939
—
—
41
151
1313
13290
70
436
1020
10305
Giant cell arteritis with polymyalgia rheumatica
M31.5 [45596562]
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.05%
—
—
—
—
—
—
—
6
7
1348
13434
—
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
2.9e-01
4.3e-01
1.3e+00
—
8.1e-01
8.5e-01
3.5e-01
cases:6.51%
controls:4.97%
cases:3.22%
controls:2.11%
cases:0.93%
controls:0.26%
—
—
cases:0.64%
controls:0.29%
cases:3.91%
controls:1.70%
cases:9.08%
controls:6.57%
91
693
1307
13263
45
295
1353
13661
13
36
1385
13920
—
9
40
1389
13874
53
229
1301
13212
99
706
991
10035
Uraemia requiring dialysis
137 [2001600133]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.07%
—
—
—
—
—
—
6
7
1084
10734
Bilateral foot X-ray examination
NH3DA [2001308279]
—
—
—
—
—
-1.0e+50
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.55%
controls:0.07%
—
—
—
—
—
0
5
1354
13436
6
7
1084
10734
Eye pressure longterm registration
XCH05 [2001311083]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.07%
—
—
—
—
—
—
6
7
1084
10734
Injury of Achilles tendon
S86.0 [45603774]
-1.0e+50
—
—
—
—
—
2.1e+00
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.07%
0
21
1398
13935
—
—
—
—
—
6
7
1084
10734
moxifloxacin; oral, parenteral
J01MA14 [21603021]
8.1e-01
7.5e-01
—
—
—
—
1.3e+00
cases:1.93%
controls:0.87%
cases:0.57%
controls:0.27%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.65%
27
121
1371
13835
8
38
1390
13918
—
—
—
—
26
70
1064
10671
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
5.5e-01
5.2e-01
—
—
-1.0e+50
8.3e-01
7.4e-01
cases:4.15%
controls:2.43%
cases:1.50%
controls:0.90%
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.85%
controls:0.81%
cases:4.40%
controls:2.15%
58
339
1340
13617
21
126
1377
13830
—
—
0
11
1398
13903
25
109
1329
13332
48
231
1042
10510
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
2.6e-01
3.4e-01
5.2e-01
—
8.5e-01
3.0e-01
3.7e-01
cases:24.11%
controls:19.68%
cases:13.73%
controls:10.20%
cases:2.72%
controls:1.63%
—
—
cases:3.22%
controls:1.40%
cases:13.66%
controls:10.46%
cases:33.12%
controls:25.43%
337
2747
1061
11209
192
1424
1206
12532
38
228
1360
13728
—
45
195
1353
13719
185
1406
1169
12035
361
2731
729
8010
insulin lispro; parenteral
A10AC04 [21600726]
1.1e+00
1.0e+00
—
—
1.0e+00
8.7e-01
6.3e-01
cases:1.57%
controls:0.54%
cases:1.22%
controls:0.43%
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.11%
controls:0.47%
cases:1.01%
controls:0.54%
22
76
1376
13880
17
60
1381
13896
—
—
6
22
1392
13892
15
63
1339
13378
11
58
1079
10683
insulin lispro; parenteral
A10AB04 [21600718]
1.1e+00
1.0e+00
—
—
1.0e+00
8.7e-01
6.3e-01
cases:1.57%
controls:0.54%
cases:1.22%
controls:0.43%
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.11%
controls:0.47%
cases:1.01%
controls:0.54%
22
76
1376
13880
17
60
1381
13896
—
—
6
22
1392
13892
15
63
1339
13378
11
58
1079
10683

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
43
60
7.36
29.35
1.9
3.0
672.05
1040.22
u/ml
0.87
43
60
982
7615
1.91
27.94
7.1
5.2
6.89
6.68
mmol/l
2.26
938
7257
607
4076
1.85
27.19
6.3
4.2
7.39
7.40
ph
0.95
446
2964
805
5920
1.82
26.50
6.9
5.0
35.82
35.41
g/l
1.38
756
5564
882
6729
1.80
25.06
11.0
7.3
1.21
1.21
mmol/l
0.04
798
5809
941
7347
1.81
24.43
12.6
9.7
4.29
4.16
e9/l
0.63
823
6367
804
6066
1.74
22.77
9.6
6.6
1.21
1.21
mmol/l
0.13
761
5608
52
113
4.74
22.54
1.2
1.2
—
—
—
0
0
54
122
4.56
22.33
2.3
2.5
11.72
54.77
iu/ml
—
6
16
847
6504
1.74
22.32
9.5
6.2
0.04
0.04
e9/l
0.04
738
5544
842
6491
1.72
21.53
9.6
6.2
0.60
0.59
e9/l
0.52
734
5534
596
4186
1.72
21.45
2.8
2.2
205.40
234.96
u/l
0.25
568
3976
673
4894
1.71
21.26
5.5
4.1
142.82
116.13
e6/l
0.12
489
3472
851
6619
1.70
20.67
9.6
6.3
1.84
1.85
e9/l
0.05
759
5774
1147
9717
1.89
20.60
11.3
8.4
81.99
79.41
u/l
0.84
1097
9231
858
6710
1.69
20.21
9.9
6.5
0.19
0.19
e9/l
0.34
756
5814
50
119
4.32
19.38
1.2
1.1
—
—
—
0
0
796
6171
1.65
18.79
19.1
16.3
1.29
1.28
inr
0.37
693
5141
1333
12028
2.50
18.71
24.7
17.1
22.42
25.65
mg/l
3.90
1129
10016
289
1706
1.87
18.35
1.5
1.3
538.40
516.03
titre
0.07
50
383
1009
8348
1.70
18.20
6.1
5.0
349.15
1645.50
e6/l
1.35
20
125
366
2329
1.77
18.12
3.7
3.1
1.09
1.25
e6/l
0.24
219
1242
596
4327
1.64
18.02
4.6
3.5
32.66
74.12
e6/l
1.60
463
3313
546
3878
1.66
17.99
9.5
6.5
—
—
—
0
0
755
5820
1.63
17.86
3.0
2.4
78.85
78.53
nmol/l
0.11
689
5219
36
72
5.10
17.20
2.9
2.5
207.24
222.67
e6/l
0.17
29
66
858
6862
1.62
17.16
8.1
6.8
11.75
11.72
umol/l
0.02
825
6559
389
2553
1.72
17.12
4.8
4.1
564.10
405.67
ng/l
0.28
310
2061
53
145
3.76
17.03
2.2
2.0
10640.00
1931.43
titre
—
5
7
43
101
4.36
16.96
3.1
2.0
38.08
40.20
%
0.36
43
101
1353
12377
2.59
16.88
29.5
20.7
3.98
3.98
mmol/l
0.03
1333
12123
477
3317
1.66
16.81
6.3
4.2
89.22
88.49
%
0.25
466
3250
1351
12359
2.56
16.70
29.0
20.5
139.55
139.63
mmol/l
0.52
1333
12122
441
3021
1.66
16.40
3.6
2.7
5.58
5.86
e6/l
0.10
399
2751
1279
11469
2.05
16.26
8.1
6.4
40.40
39.24
mmol/mol
4.34
1209
10682
35
72
4.96
16.20
2.8
2.2
516.69
636.56
e6/l
0.36
26
62
1261
11257
1.98
16.16
6.1
5.4
2.02
1.95
mu/l
0.84
1180
10383
1370
12643
2.79
16.12
17.5
12.5
27.33
25.97
u/l
0.92
1339
12273
703
5426
1.58
15.81
4.5
3.6
6.28
6.25
ph
0.31
385
3032
848
6836
1.59
15.78
5.1
4.0
0.03
0.23
estimate
0.44
153
1373
1377
12765
2.89
15.58
31.4
22.5
84.68
78.72
umol/l
3.88
1366
12604
833
6719
1.57
15.20
5.1
4.0
0.00
0.00
estimate
-0.00
158
1422
840
6793
1.57
15.12
5.1
4.0
0.00
4.27
estimate
1.34
158
1461
331
2141
1.71
15.11
3.7
3.2
2.10
2.41
e6/l
0.39
177
1050
758
5996
1.56
15.00
10.0
6.4
2.76
2.80
%
0.16
705
5606
588
4393
1.57
14.98
9.8
6.2
—
—
—
0
0
494
3551
1.60
14.82
4.2
3.3
0.00
0.00
estimate
—
5
16
42
108
3.98
14.73
2.9
2.0
1106.67
1242.99
e6/l
0.44
36
100
758
6011
1.55
14.72
9.9
6.4
58.72
57.81
%
1.26
717
5725
768
6110
1.55
14.68
10.1
6.5
26.23
27.13
%
1.44
725
5793
757
6014
1.55
14.49
10.2
6.5
9.11
8.93
%
1.00
709
5631
1136
9923
1.69
14.40
30.2
21.2
13.81
13.71
%
1.65
1119
9792
26
46
5.74
14.17
26.1
32.2
108.05
131.73
ug/l
1.03
19
37
319
2077
1.69
14.10
2.9
2.0
29.26
29.70
s
0.67
314
2021
750
5995
1.53
13.61
10.2
6.5
0.66
0.67
%
0.07
699
5608
84
349
2.49
13.13
2.3
2.2
13.99
12.14
mg/l
0.74
79
324
549
4128
1.53
13.11
3.8
3.4
—
—
—
0
0
23
39
5.98
13.08
2.0
1.5
—
—
—
0
0
504
3729
1.54
12.92
4.3
3.4
0.39
0.41
e6/l
0.05
375
2742
27
55
4.98
12.65
1.1
1.2
—
—
—
0
0
317
2116
1.64
12.57
4.0
2.6
2.29
2.29
g/l
0.02
290
1959
556
4232
1.51
12.34
3.3
3.2
2123.33
1436.25
ng/l
0.92
490
3648
1384
13017
2.71
12.29
37.2
26.0
6.80
6.76
e9/l
0.18
1360
12710
224
1370
1.75
12.29
8.3
3.4
1.55
1.96
mmol/l
1.04
201
1174
1083
9477
1.58
12.21
4.9
4.3
14.86
14.90
pmol/l
0.24
1002
8675
250
1580
1.70
12.19
5.4
2.6
1.77
1.81
%
0.26
224
1402
49
159
3.16
12.17
1.2
1.2
4.03
6.06
u/ml
0.46
29
71
1383
13010
2.68
12.15
37.3
25.9
245.18
248.05
e9/l
0.92
1364
12742
1383
13013
2.67
12.09
37.1
25.9
91.36
91.34
fl
0.05
1372
12871
1383
13015
2.67
12.05
37.2
25.9
4.42
4.46
e12/l
1.83
1357
12712
1383
13015
2.67
12.05
37.1
25.8
30.33
30.38
pg
0.46
1372
12872
1383
13015
2.67
12.05
37.9
26.4
39.85
40.47
%
0.98
1372
12866
599
4649
1.49
12.01
3.5
3.5
2.35
2.36
mmol/l
0.22
557
4202
1383
13018
2.66
11.99
37.5
26.1
133.05
134.41
g/l
2.72
1372
12877
953
8124
1.51
11.98
4.1
3.4
59.59
50.33
u/l
1.32
911
7633
99
461
2.23
11.98
1.6
1.3
—
—
—
0
0
100
471
2.21
11.77
3.9
1.9
22.78
21.09
s
0.35
91
424
295
1967
1.63
11.66
4.0
2.6
21.32
22.53
%
0.84
275
1833
228
1422
1.72
11.63
8.1
3.4
7.37
7.38
ph
0.80
135
817
1325
12280
2.01
11.61
19.8
15.4
—
—
—
0
0
55
197
2.86
11.52
1.6
1.7
0.56
0.85
g/l
1.44
43
159
106
516
2.14
11.49
2.5
1.9
10.28
8.29
iu/ml
0.21
23
119
147
806
1.92
11.46
2.6
2.6
18.53
22.16
au/ml
0.22
17
74
278
1841
1.63
11.26
11.7
5.6
1.05
1.03
mmol/l
0.63
263
1697
198
1201
1.75
11.13
11.4
9.1
—
—
—
0
0
136
735
1.94
11.07
1.4
1.4
29.50
55.26
au/ml
—
6
48
693
5597
1.46
11.05
15.2
11.9
0.00
0.00
e9/l
0.67
563
4568
194
1175
1.75
10.96
3.2
2.9
66.67
66.54
g/l
0.08
174
1084
45
148
3.11
10.95
1.2
1.2
—
—
—
0
0
1287
11856
1.82
10.91
6.0
5.1
4.42
4.60
mmol/l
8.17
1210
11027
170
992
1.81
10.89
3.5
2.9
10.26
10.78
g/l
0.87
160
912
183
1092
1.77
10.88
3.2
3.1
220.64
214.43
ng/l
0.08
159
1012
1305
12077
1.88
10.84
6.9
5.9
2.53
2.67
mmol/l
7.19
1222
11177
1282
11803
1.80
10.80
5.9
5.0
1.45
1.46
mmol/l
0.52
1196
10901
192
1169
1.74
10.64
2.8
2.4
5.53
7.23
ug/l
0.91
172
1034
252
1650
1.64
10.63
7.5
8.0
4.96
5.12
kpa
1.72
239
1590
725
5933
1.45
10.62
2.4
2.2
92.08
95.46
pmol/l
1.11
378
3091
551
4281
1.47
10.62
4.4
3.3
65.79
44.41
mg/l
1.13
387
2737
38
115
3.37
10.58
2.0
2.3
—
—
—
0
0
231
1481
1.67
10.58
4.6
2.8
11.11
8.34
umol/l
0.77
193
1308
327
2285
1.56
10.48
4.1
2.6
11.98
12.68
umol/l
1.04
304
2130
251
1648
1.63
10.46
7.5
8.0
7.41
7.41
ph
0.04
139
917
58
226
2.63
10.38
2.1
1.3
—
—
—
0
0
251
1651
1.63
10.38
7.5
8.0
12.68
12.11
kpa
0.78
238
1596
573
4506
1.45
10.28
4.3
3.3
6.83
7.53
mmol/l
3.92
508
3827
501
3840
1.47
10.28
5.8
4.5
—
—
—
0
0
45
154
2.98
10.25
1.1
1.1
116.44
118.28
%
0.12
39
141
558
4369
1.45
10.23
5.2
4.0
12.25
7.57
mg/mmol
1.04
384
2726
249
1641
1.63
10.21
7.4
8.0
0.34
1.04
mmol/l
1.92
207
1357
122
655
1.94
10.12
2.4
1.8
1.45
1.61
g/l
0.93
108
567
184
1124
1.73
10.06
3.5
2.4
0.61
0.50
e6/l
0.24
175
1071
705
5779
1.43
10.01
4.6
3.0
139.91
134.89
ug/l
0.16
654
5366
55
213
2.65
9.98
2.2
1.4
118.91
154.71
au/ml
0.85
15
57
175
1060
1.74
9.85
6.2
3.8
102.84
88.94
ng/l
0.77
153
914
200
1257
1.69
9.84
13.8
6.9
11.14
10.08
mmol/l
1.26
193
1203
226
1473
1.63
9.66
7.6
8.3
95.31
95.46
%
0.11
218
1428
196
1232
1.68
9.64
4.4
2.6
69.10
68.62
e9/l
0.06
138
894
149
870
1.80
9.51
1.9
1.7
—
—
—
0
0
459
3501
1.46
9.50
2.8
2.2
2.96
2.88
mg/l
0.20
399
2988
36
113
3.24
9.49
1.5
1.2
0.35
0.41
g/l
0.55
27
83
36
113
3.24
9.49
1.5
1.2
2.98
2.86
g/l
0.14
27
83
36
113
3.24
9.49
1.5
1.2
7.06
7.03
g/l
0.02
26
82
229
1508
1.62
9.37
2.6
1.7
—
—
—
0
0
535
4213
1.43
9.27
4.7
3.2
36.49
33.35
u/l
0.72
508
3984
197
1253
1.66
9.25
3.2
2.5
43.12
41.10
u/l
0.10
168
1063
211
1366
1.64
9.24
8.3
8.8
118.23
120.98
g/l
1.19
205
1338
356
2599
1.49
9.15
3.4
3.0
500.51
530.17
mosm/kgh2o
1.94
300
2259
463
3575
1.44
8.85
3.8
3.1
0.15
0.03
0.34
13
90
521
4110
1.42
8.84
3.5
2.6
54.58
81.50
u/l
0.77
485
3812
321
2310
1.50
8.81
5.1
3.2
0.82
0.82
mmol/l
0.07
301
2175
1266
11743
1.66
8.72
6.1
5.3
6.09
5.95
mmol/l
2.64
1176
10736
35
114
3.12
8.70
1.5
1.2
—
—
—
0
0
1226
11291
1.58
8.62
5.1
4.3
1.29
1.29
mmol/l
0.02
1145
10329
135
790
1.78
8.55
2.4
1.8
1.36
1.46
g/l
0.14
122
722
331
2431
1.47
8.14
1.7
1.5
2.24
2.50
g/l
1.76
201
1462
394
3016
1.42
7.71
5.5
4.2
1.02
1.52
kg/l
0.50
283
2002
366
2765
1.43
7.70
2.9
3.0
2.46
2.46
mmol/l
0.07
330
2485
367
2794
1.42
7.36
2.6
1.7
1.13
1.30
mg/l
0.74
293
2174
196
1317
1.57
7.30
2.1
1.6
—
—
—
0
0
140
866
1.68
7.29
7.4
6.6
23.93
24.47
mmol/l
1.14
132
830
52
229
2.32
7.26
1.5
1.2
305.45
252.67
u/ml
0.68
38
130
118
698
1.75
7.22
3.0
3.6
4.35
4.53
pmol/l
1.13
104
616
16
22
7.34
7.19
2.8
1.8
0.12
0.25
e9/l
—
7
8
488
3921
1.37
7.05
1.9
1.7
22.18
20.13
nmol/l
1.97
418
3291
18
43
4.23
7.02
3.8
2.9
0.59
0.60
mmol/l
0.08
18
43
703
5983
1.34
6.94
3.6
2.9
—
—
estimate
—
0
0
91
505
1.86
6.88
2.7
2.6
9.86
10.48
g/l
0.90
81
453
426
3360
1.38
6.87
3.6
2.8
346.82
346.65
umol/l
0.01
385
2967
76
398
1.96
6.84
1.1
1.1
—
—
—
0
0
58
275
2.16
6.81
1.3
1.3
57.69
60.34
mmol/l
0.19
51
223
15
21
7.21
6.71
1.1
1.0
—
—
—
0
0
610
5104
1.34
6.67
4.2
4.0
87.79
71.74
ng/l
0.12
465
3756
308
2309
1.43
6.65
1.8
1.8
1161.50
1181.39
nmol/l
0.12
245
1717
230
1634
1.49
6.59
2.0
1.6
—
—
—
0
0
263
1924
1.45
6.48
2.8
2.0
—
—
—
0
0
519
4270
1.34
6.25
3.3
2.5
—
—
—
0
0
19
52
3.69
6.21
1.3
1.1
1536.63
1457.29
miu/ml
0.10
19
52
247
1801
1.45
6.17
1.3
1.2
—
—
—
0
0
355
2760
1.38
6.15
1.4
1.3
3.48
1.54
u/ml
0.84
95
740
216
1539
1.47
6.08
2.3
2.4
148.57
129.80
ug/g
0.26
170
1242
37
155
2.42
5.82
3.1
2.5
1.29
1.33
g/24h
0.04
21
93
36
149
2.45
5.81
1.3
1.4
0.20
0.19
nmol/l
0.21
26
119
260
1934
1.42
5.81
2.2
1.8
—
—
—
0
0
104
634
1.69
5.75
1.9
2.1
—
—
—
0
0
83
479
1.78
5.57
1.4
1.2
0.39
0.98
u/ml
—
9
34
204
1463
1.46
5.54
1.4
1.3
—
—
—
0
0
70
384
1.87
5.53
8.9
3.0
1.71
1.61
mg/l
0.45
65
349
25
88
2.87
5.53
3.0
2.6
39.96
40.19
%
—
8
45
301
2315
1.38
5.51
1.3
1.3
47.69
33.31
iu/ml
0.68
98
710
42
191
2.24
5.51
1.2
1.1
—
—
—
0
0
66
356
1.90
5.50
1.5
1.3
—
—
—
0
0
459
3777
1.32
5.34
5.4
4.2
0.00
0.00
estimate
0.96
141
1325
594
5066
1.29
5.28
5.0
4.0
0.00
0.04
estimate
1.28
133
1171
65
357
1.86
5.14
1.2
1.2
83.75
104.17
titre
—
8
36
173
1221
1.47
5.10
2.3
2.1
397.43
383.73
nmol/l
0.44
161
1126
133
891
1.54
5.03
5.4
2.8
126.83
128.01
g/l
0.24
127
866
129
859
1.55
5.01
8.2
10.2
24.03
24.41
mmol/l
0.64
123
844
21
71
2.99
4.99
1.0
1.1
11.30
8.47
iu/ml
—
5
20
120
794
1.56
4.80
10.9
10.5
15.81
15.87
%
0.09
114
767
276
2164
1.34
4.40
1.3
1.3
19.47
13.24
u/ml
0.55
107
796
574
4957
1.26
4.38
2.3
2.2
—
—
—
0
0
15
45
3.36
4.33
3.1
1.4
2.13
1.99
umol/l
0.32
15
38
173
1261
1.42
4.31
2.5
2.1
0.07
0.02
estimate
0.32
28
262
340
2759
1.30
4.25
5.9
4.7
—
—
—
0
0
36
173
2.11
4.19
1.7
1.8
—
—
—
0
0
79
490
1.65
4.16
3.5
3.6
30.07
67.63
mg/l
0.94
71
421
79
490
1.65
4.16
3.5
3.6
39.73
61.79
mg/l
1.06
72
422
128
892
1.48
4.05
1.8
1.5
—
—
—
0
0
23
93
2.50
3.97
1.3
1.1
31.09
35.53
mmol/l
0.50
23
85
206
1572
1.36
3.91
1.8
1.5
—
—
—
0
0
482
4133
1.25
3.79
5.6
5.5
2.36
2.61
ug/l
0.28
440
3732
176
1317
1.38
3.77
2.8
2.2
0.21
0.21
g/l
0.09
166
1229
111
765
1.49
3.72
5.8
2.4
1.12
1.21
%
0.58
111
760
15
50
3.02
3.69
2.1
1.8
29.73
31.44
%
0.24
15
50
582
5108
1.23
3.67
2.0
1.9
1.31
1.36
mmol/l
0.98
501
4295
333
2750
1.27
3.58
1.9
1.7
21661123.91
22436893.91
pmol/l
0.01
277
2282
54
317
1.73
3.52
2.3
1.3
448.25
558.44
mg/l
1.75
48
299
15
52
2.90
3.47
1.2
1.1
473.73
189.65
iu/ml
0.93
15
52
11
28
3.95
3.29
1.0
1.0
—
—
—
0
0
44
249
1.79
3.27
2.2
1.4
—
—
—
0
0
7
11
6.39
3.18
5.6
3.2
—
—
—
0
0
201
1578
1.32
3.16
3.4
3.4
5.20
5.04
e9/l
0.06
176
1363
28
138
2.05
3.12
2.5
2.4
—
—
—
0
0
68
439
1.58
3.11
3.5
3.6
13.83
3.43
ratio
0.61
43
244
25
118
2.14
3.11
1.2
1.2
—
—
—
0
0
27
132
2.07
3.08
1.8
1.5
—
—
—
0
0
53
324
1.66
3.02
1.8
1.9
5.41
21.16
iu/l
0.44
23
134
17
69
2.48
2.96
1.2
1.2
—
—
—
0
0
151
1149
1.35
2.94
1.6
1.4
—
—
—
0
0
63
406
1.58
2.92
7.6
6.1
1.32
1.35
mmol/l
0.10
57
360
11
32
3.46
2.90
2.5
1.6
—
—
—
0
0
45
267
1.71
2.88
2.9
2.3
106.96
124.08
ug/min
0.12
29
164
22
102
2.17
2.87
1.3
1.1
—
—
—
0
0
7
13
5.41
2.87
1.7
1.5
—
—
—
0
0
46
275
1.69
2.86
2.3
1.4
14.89
70.38
e6/l
1.05
35
202
134
1006
1.37
2.85
3.1
2.8
6.11
6.06
ph
0.25
96
693
11
33
3.35
2.81
7.1
4.6
—
—
—
0
0
28
144
1.96
2.81
1.8
1.4
—
—
nmol/l
—
0
0
10
28
3.59
2.78
1.3
1.1
—
—
—
0
0
94
667
1.44
2.78
2.6
2.4
—
—
—
0
0
46
278
1.68
2.76
2.3
1.5
253.78
669.29
e6/l
0.43
37
214
83
577
1.47
2.73
7.0
5.0
0.85
0.87
%
0.25
75
544
61
397
1.56
2.73
1.4
1.5
230.78
277.26
ug/g
1.11
34
234
11
35
3.16
2.64
1.1
1.1
—
—
—
0
0
46
283
1.65
2.60
2.3
1.2
3.72
3.71
mmol/l
0.01
41
266
20
94
2.14
2.55
1.4
1.1
—
—
—
0
0
12
42
2.87
2.55
1.3
1.4
129.75
173.68
mmol/24h
0.98
12
42
6
11
5.47
2.54
1.8
1.5
—
—
—
0
0
182
1456
1.29
2.51
3.6
4.3
14.08
16.13
ug/l
0.09
145
1198
45
279
1.63
2.48
9.1
7.0
11.62
11.25
mmol/l
0.37
39
253
45
279
1.63
2.48
9.1
7.0
104.26
105.58
mmol/l
0.75
39
253
28
151
1.87
2.48
1.5
1.4
—
—
—
0
0
76
531
1.46
2.46
2.7
2.7
—
—
—
0
0
85
610
1.42
2.40
2.4
1.9
1.66
1.53
ug/l
0.08
76
546
19
90
2.13
2.39
2.9
2.3
645.42
608.05
ml
0.18
12
63
8
22
3.65
2.36
1.0
1.0
16.48
57.52
iu/ml
—
8
22
10
33
3.04
2.36
1.1
1.4
26.30
28.45
s
—
10
33
17
78
2.19
2.31
1.1
1.0
—
—
—
0
0
68
472
1.46
2.30
3.5
3.3
289.87
378.97
mg/l
0.30
39
204
205
1683
1.25
2.30
1.4
1.3
—
—
—
0
0
114
867
1.34
2.28
1.2
1.3
—
—
—
0
0
395
3480
1.19
2.18
1.5
1.4
—
—
—
0
0
31
181
1.73
2.16
2.1
1.6
—
—
—
0
0
31
181
1.73
2.16
2.1
1.6
—
—
—
0
0
31
181
1.73
2.16
2.1
1.6
—
—
—
0
0
31
181
1.73
2.16
2.1
1.6
—
—
—
0
0
26
144
1.82
2.15
1.3
1.3
276.94
277.30
mosm/kgh2o
0.02
18
105
17
81
2.11
2.13
1.8
1.6
111.36
96.77
ng/l
0.47
17
81
68
480
1.44
2.13
3.7
2.7
23.97
24.78
mmol/l
1.08
68
473
86
635
1.38
2.09
6.9
4.8
1.59
1.56
%
0.10
78
599
104
794
1.33
2.05
1.2
1.2
131.61
129.83
u/ml
0.02
29
306
40
255
1.58
2.02
1.3
1.2
—
—
—
0
0
61
427
1.45
2.01
1.6
1.6
20.56
14.66
u/ml
0.33
13
97
9
32
2.82
2.00
1.9
1.7
—
—
—
0
0
24
133
1.82
2.00
2.8
1.6
—
—
—
0
0
44
288
1.54
1.99
3.2
2.9
89.43
89.65
%
0.06
44
275
75
547
1.39
1.97
2.3
3.3
1289.08
2733.57
u/ml
0.33
62
483
113
879
1.31
1.96
3.7
3.8
7.42
7.42
ph
0.28
100
737
33
203
1.64
1.93
1.1
1.1
—
—
—
0
0
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
55
385
1.45
1.83
12.1
10.5
—
—
—
0
0
5
12
4.18
1.82
1.2
1.0
128.00
77.33
titre
—
5
12
42
280
1.52
1.78
1.8
2.0
213.93
211.30
pmol/l
0.06
42
265
19
102
1.87
1.76
1.6
1.1
127.89
104.18
pmol/l
0.93
19
102
43
292
1.49
1.68
1.7
1.5
10.44
9.01
u/l
0.18
33
228
157
1303
1.23
1.64
1.7
1.6
—
—
—
0
0
19
105
1.82
1.63
3.1
2.4
13.06
7.79
umol/l
0.54
14
71
26
158
1.66
1.63
1.5
1.4
35672.71
32654.10
e6/l
0.07
14
84
8
32
2.51
1.59
1.8
1.2
—
—
—
0
0
50
356
1.42
1.56
1.5
1.6
14787.05
14786.20
e6/l
0.00
39
254
23
138
1.68
1.52
1.4
1.7
21.13
33.44
ng/l
0.77
23
138
13
65
2.01
1.49
1.5
1.4
0.53
1.29
nmol/l
—
7
47
23
139
1.67
1.48
5.2
1.7
11.66
10.45
%
0.94
23
139
69
525
1.33
1.46
1.4
1.7
0.38
0.33
mg/l
0.25
41
251
51
370
1.39
1.45
3.3
3.3
1.88
2.25
index
0.14
25
193
28
180
1.57
1.43
1.5
1.4
1225.58
1686.44
e6/l
0.31
19
123
143
1195
1.22
1.42
5.6
4.4
1.12
0.93
%
0.44
47
385
10
46
2.18
1.40
1.1
1.2
—
—
—
0
0
11
53
2.08
1.38
2.5
1.9
39.78
40.42
g/l
0.11
11
53
9
42
2.15
1.33
1.3
1.4
—
—
—
0
0
22
136
1.63
1.33
1.2
1.5
1.20
1.31
mm
0.90
14
104
45
326
1.39
1.31
1.3
1.3
285.01
237.37
miu/ml
0.31
20
144
278
2478
1.15
1.31
3.0
3.3
0.71
0.76
ug/l
0.57
189
1623
6
24
2.51
1.30
1.2
1.5
—
—
—
0
0
12
62
1.94
1.28
2.5
2.8
—
—
—
0
0
22
138
1.60
1.26
1.2
1.5
—
—
—
0
0
44
320
1.39
1.26
1.8
1.6
—
—
—
0
0
23
147
1.57
1.23
1.6
1.5
—
—
—
0
0
24
155
1.56
1.23
1.5
1.2
—
—
—
0
0
36
501
0.71
1.22
1.6
1.7
—
—
—
0
0
22
141
1.57
1.17
1.3
1.6
—
—
—
0
0
388
3560
1.12
1.17
4.4
3.5
0.08
0.03
estimate
0.24
129
1124
17
102
1.67
1.16
1.7
1.2
—
—
—
0
0
0
34
0.00
1.16
0.0
3.0
—
—
—
0
0
80
644
1.26
1.15
1.4
1.2
—
—
—
0
0
19
118
1.62
1.15
1.3
1.1
—
—
—
0
0
48
363
1.33
1.11
1.2
1.1
—
—
—
0
0
24
160
1.51
1.09
1.1
1.2
—
—
—
0
0
79
641
1.25
1.08
2.6
2.2
0.00
1.27
estimate
0.50
23
198
134
1149
1.18
1.06
5.6
4.7
0.06
0.12
%
0.50
36
304
73
589
1.25
1.05
1.2
1.2
—
—
—
0
0
5
22
2.28
1.03
4.0
2.2
12.06
17.63
umol/l
—
5
22
15
91
1.66
1.00
1.0
1.0
450.56
262.00
ng/l
—
9
58
15
91
1.66
1.00
1.0
1.0
1017.00
683.98
ng/l
—
7
56
15
91
1.66
1.00
1.5
2.4
9.54
8.58
mmol/l
0.29
15
91
121
1034
1.19
1.00
2.6
2.4
12.81
13.12
nmol/l
0.15
112
941
21
139
1.52
1.00
3.2
2.5
—
—
—
0
0
17
107
1.60
1.00
1.1
1.1
—
—
—
0
0
22
148
1.49
0.98
1.6
1.7
—
—
—
0
0
132
1140
1.17
0.97
5.1
4.1
0.57
0.74
%
0.73
44
362
10
54
1.86
0.96
1.6
1.1
64.60
377.27
ng/l
—
5
11
21
141
1.50
0.95
1.0
1.1
—
—
—
0
0
54
427
1.27
0.94
1.6
1.4
31.08
28.82
iu/l
0.18
45
355
33
243
1.37
0.93
3.5
1.5
0.72
0.91
nmol/l
0.76
26
202
25
175
1.44
0.93
1.4
1.6
68.42
61.57
ug/l
0.20
20
150
12
70
1.72
0.92
1.4
1.6
—
—
—
0
0
37
278
1.34
0.92
4.6
3.0
61.69
58.15
%
1.14
37
278
124
1075
1.17
0.89
4.3
3.9
1.23
1.23
mmol/l
0.34
106
934
125
1085
1.17
0.88
1.9
2.1
3.37
3.54
ratio
0.89
96
864
15
95
1.59
0.87
1.8
1.6
1.03
1.09
promille
0.06
15
72
130
1135
1.16
0.86
5.7
4.4
0.09
0.13
%
0.24
34
323
21
145
1.45
0.85
1.6
1.6
52.14
63.00
%
0.58
14
94
138
1566
0.87
0.84
5.2
4.9
34.75
32.49
%
1.58
100
1012
112
968
1.17
0.84
1.2
1.2
—
—
—
0
0
12
73
1.65
0.81
1.3
1.2
119.92
137.39
nmol/l
0.81
12
73
74
620
1.20
0.80
3.6
4.0
—
—
—
0
0
6
33
1.82
0.79
4.2
3.1
3.83
858.82
ug/l
—
6
33
24
173
1.39
0.79
1.2
1.3
—
—
—
0
0
16
106
1.52
0.79
1.4
1.4
12.19
13.18
u/l
0.24
16
99
42
331
1.28
0.78
2.6
2.2
129.70
127.25
g/l
0.25
37
262
13
82
1.59
0.78
1.9
2.6
14.85
16.30
%
0.94
13
82
141
1249
1.14
0.78
5.7
4.5
7.35
7.36
ph
0.35
112
912
0
28
0.00
0.76
0.0
2.3
—
2.75
—
0
28
10
59
1.70
0.76
2.5
2.3
34.26
47.77
umol/l
—
10
48
35
271
1.30
0.75
1.8
2.2
875.64
4757.03
u/l
—
9
110
19
265
0.71
0.73
1.3
1.2
—
—
—
0
0
5
25
2.00
0.72
1.0
1.0
9.35
6.10
mg/g
—
5
25
5
28
1.79
0.66
1.8
1.4
5.64
8.42
mmol/l
—
5
28
15
103
1.46
0.65
1.9
1.5
—
—
—
0
0
29
224
1.30
0.65
4.2
3.1
4.27
4.16
e9/l
0.14
29
224
26
198
1.32
0.64
1.2
2.0
0.93
0.88
%
0.16
18
134
420
4424
0.93
0.63
3.7
3.2
—
—
—
0
0
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
31
244
1.28
0.61
1.6
1.2
18.75
42.91
u/l
1.63
25
215
26
200
1.31
0.61
3.0
2.4
—
—
—
0
0
12
80
1.50
0.60
1.2
1.4
152.16
162.18
pmol/l
0.14
12
80
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
19
140
1.36
0.58
1.8
1.4
0.91
0.33
nmol/l
0.38
11
104
23
176
1.31
0.56
1.0
1.1
0.37
2.42
u/ml
—
8
76
17
124
1.38
0.55
3.5
3.3
20.25
12.22
index
—
8
73
12
82
1.47
0.54
1.0
1.0
—
—
—
0
0
23
178
1.30
0.53
1.0
1.0
1.48
5.72
u/ml
2.41
11
94
13
91
1.43
0.53
1.7
1.5
8.37
2.73
ug/l
0.48
13
76
36
297
1.22
0.50
5.1
3.8
—
—
—
0
0
19
146
1.31
0.47
1.4
1.2
—
—
—
0
0
21
164
1.28
0.46
1.3
1.3
—
—
—
0
0
18
138
1.31
0.45
1.8
1.8
—
—
—
0
0
36
303
1.19
0.43
1.5
1.6
944.86
1015.95
mu/l
0.18
29
256
38
322
1.19
0.42
1.2
1.2
—
—
—
0
0
15
113
1.33
0.42
1.2
1.4
29.67
30.24
%
—
9
73
16
122
1.31
0.42
1.2
1.2
—
—
—
0
0
20
158
1.27
0.42
1.5
1.4
6.00
6.36
mmol/l
0.21
20
148
8
58
1.38
0.41
1.4
1.3
—
1.91
%
—
0
11
11
150
0.73
0.41
1.1
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
1.74
—
0
16
0
17
0.00
0.40
0.0
1.1
—
0.02
—
0
17
5
36
1.39
0.38
1.0
1.8
77.40
100.08
nmol/24h
—
5
36
10
136
0.73
0.37
1.0
1.0
—
0.41
—
0
49
17
134
1.27
0.37
1.7
2.4
—
—
—
0
0
9
71
1.27
0.36
3.3
1.7
—
—
—
0
0
29
339
0.85
0.33
1.4
2.2
—
—
—
0
0
32
366
0.87
0.29
1.4
2.0
—
—
—
0
0
34
298
1.14
0.28
4.1
3.7
214.14
1319.06
u/ml
0.69
29
280
31
270
1.15
0.28
1.5
1.5
204.21
267.90
pmol/l
0.24
31
264
36
319
1.13
0.26
5.6
4.6
—
—
—
0
0
86
801
1.08
0.25
1.7
1.8
3.12
3.50
mmol/l
2.66
54
580
6
85
0.70
0.24
1.7
2.0
21.50
19.77
nmol/l
—
6
76
18
152
1.19
0.23
13.8
4.9
7.23
7.33
mmol/l
0.05
18
127
5
41
1.22
0.22
4.2
2.7
28.20
16.95
ug/l
—
5
34
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
0.22
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
24
211
1.14
0.20
1.1
1.1
0.17
1.94
u/ml
2.65
12
119
6
48
1.25
0.20
5.2
2.0
—
—
—
0
0
51
552
0.92
0.20
1.1
1.1
—
—
—
0
0
6
49
1.23
0.20
1.3
1.6
0.52
3.59
%
—
6
42
6
49
1.23
0.20
1.3
1.4
16.50
26.90
%
—
6
44
10
120
0.83
0.16
2.0
2.5
—
—
—
0
0
8
71
1.13
0.16
2.0
1.4
11.46
25.26
umol/l
—
8
62
11
92
1.20
0.16
1.5
1.6
—
—
—
0
0
11
92
1.20
0.16
1.0
1.3
—
—
—
0
0
31
284
1.09
0.15
3.0
2.6
16.33
15.85
%
0.42
31
277
34
368
0.92
0.14
1.4
2.1
—
—
—
0
0
34
368
0.92
0.14
1.4
2.1
—
—
—
0
0
18
160
1.13
0.14
1.2
2.7
—
—
—
0
0
41
383
1.07
0.13
1.1
1.1
1.48
1.53
g/l
0.51
41
383
33
356
0.93
0.13
1.1
1.1
0.58
0.68
ratio
—
10
52
34
365
0.93
0.12
1.4
2.1
—
—
—
0
0
10
85
1.18
0.12
2.6
2.3
1.80
2.96
ug/l
—
10
80
32
297
1.08
0.12
1.1
1.3
—
—
—
0
0
15
134
1.12
0.11
1.2
1.3
19901.22
105063.37
e6/l
—
9
89
36
338
1.07
0.11
3.3
3.5
0.69
0.79
nmol/l
1.38
29
283
14
125
1.12
0.10
1.5
1.6
3.36
3.97
mg/l
0.32
14
120
5
45
1.11
0.09
4.2
3.8
—
—
—
0
0
22
203
1.09
0.09
3.4
2.6
—
—
—
0
0
20
217
0.92
0.09
2.5
1.9
1.70
1.62
mmol/l
0.17
20
210
5
61
0.82
0.08
7.0
8.4
4.06
294.92
ug/l
—
5
42
7
81
0.86
0.07
1.3
1.5
144.71
82.54
umol/l
—
7
81
20
188
1.06
0.05
1.2
1.1
—
—
—
0
0
20
188
1.06
0.05
1.2
1.1
—
—
—
0
0
16
170
0.94
0.04
1.0
1.1
0.45
2.15
u/ml
—
8
85
23
220
1.05
0.03
1.7
1.6
—
—
—
0
0
15
152
0.99
0.00
1.2
1.1
—
—
—
0
0
27
269
1.00
0.00
5.1
4.9
2.52
2.68
mmol/l
0.12
20
182
27
273
0.99
0.00
3.4
3.8
35.47
27.89
mg/l
0.40
19
196
105
1047
1.00
0.00
1.3
1.4
—
—
—
0
0
102
1015
1.01
0.00
4.7
4.2
—
—
—
0
0
8
83
0.96
0.00
2.6
2.2
1.77
1.81
ug/l
—
8
69
0
6
0.00
0.00
0.0
4.5
—
99.67
—
0
6
0
6
0.00
0.00
0.0
1.5
—
0.17
—
0
6
0
6
0.00
0.00
0.0
1.0
—
33.72
—
0
6
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
-0.00
1.8
1.2
12.60
10.52
mm/h
—
5
50
0
8
0.00
-0.00
0.0
1.3
—
55.95
—
0
8
5
49
1.02
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
402.00
—
0
5
5
49
1.02
-0.00
4.2
3.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.03
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.1
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_RETINANAS and mortality.

Females

Parameter HR [95% CI] p-value
H7_RETINANAS 0.998 [0.87, 1.15] 0.977
Birth year 0.996 [0.99, 1.0] 0.289

During the follow-up period (1.1.1998 — 31.12.2019), 685 out of 3642 females with H7_RETINANAS died.

Males

Parameter HR [95% CI] p-value
H7_RETINANAS 1.067 [0.91, 1.25] 0.416
Birth year 0.988 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 601 out of 3031 males with H7_RETINANAS died.

Mortality risk

Mortality risk for people of age

years, who have H7_RETINANAS.

N-year risk Females Males
1 0.1% 0.25%
5 0.647% 1.275%
10 1.654% 3.094%
15 3.085% 6.093%
20 5.306% 10.422%

Relationships between endpoints

↥

Index endpoint: H7_RETINANAS – Other specified and unspecified retinal disorders

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data